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The plant hormone cytokinin is responsible for regulation of a diverse set of biological 
and developmental phenomena in plants such as leaf senescence, organ formation, nutrient 
distribution, abiotic stress response, and others. The core components of the cytokinin signaling 
pathway have been identified and characterized in Arabidopsis thaliana and other plant species, 
but questions remain about whether biological factors exist that may participate in or regulate the 
pathway.  
In this work, I present the results of a sensitized genetic screen for enhancers of ahp (eah) 
mutants which are hyposensitive to exogenously supplied cytokinin signals. The eah screen 
identified several new alleles of ahk4, one of the cytokinin receptors in Arabidopsis, as well as 
implicating the light-signaling transcription factor HY5. As part of the screen, the 
“mutagenomics” strategy for analyzing uncharacterized mutants in a screen was developed. 
Mutagenomics involves high-throughput resequencing of a small number of mutant plants with 
the goal of detecting protein-altering single nucleotide polymorphisms (SNPs). The SNPs 
detected across the experiment are then assessed to determine if any genes were mutated more 
frequently than would be expected by chance alone. A second aspect of mutagenomics involves 
resequencing plant lines of common descent, referred to as siblings, to determine which 
mutations are homozygous in all related plants. The causative mutation should be contained in 
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the list of shared homozygous mutations. The mutagenomics strategies have the potential to 
accelerate the pace of genetic screens. 
I also present a primer design tool, indCAPS, developed to aid the search for novel 
CRISPR/Cas9-derived mutant alleles. The indCAPS platform is intended to be used for Cleaved 
Amplified Polymorphic Sequence (CAPS) or derived CAPS (dCAPS) restriction-digest 
genotyping assays. Tools exist for designing dCAPS primers but they assume the researcher is 
genotyping a SNP allele. CRISPR/Cas9-derived alleles are typically insertion/deletion (indel) 
events that result in a frameshift of a protein, and the previously developed primer design tools 
often fail when given sequences with indels. The indCAPS platform was developed with the 
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CHAPTER 1: INTRODUCTION 
If you examine the myriad sub-domains of biology, you can find groups of scientists so 
separated in subject matter, cross-referencing, collaboration, and typical methodology that an 
ecologist might define them as different species (if “ecology of science” was a thing, that is). 
However, all biologists share the same core goal: to study life. The form and technique may 
vary, but the ambition is the same. Many of the biological phenomena that allow a fruit fly or 
fish or worm to live are the same phenomena that keep rats and mice and our own bodies alive. 
Plant biology is no different, but if you will permit me a moment of romanticisim, plant biology 
has a certain importance in the role plants have in maintaining our lives. Life as we know it 
would not be possible without plants. Land plants and ocean algae are responsible for the oxygen 
we breathe; the food we and our animals eat; the material resources we use to build our homes, 
publish our books and newspapers, and power our engines; and the stabilization of the land 
against erosion and flooding. The study of plants is the study of the keystone holding human 
civilization upright.  
Regrettably however, plants are unglamorous. To most people, they are static organisms 
that fill in the backdrops of their everyday lives. However, the same factors that make plants 
unremarkable when compared to animals also make them scientifically interesting and brought 
me to love them. No, plants are not capable of large movements. If a predator threatens a plant, it 
cannot run away or hide. Instead, it must change its biology, and that is truly fascinating. A plant 
reacts to its environment by changing its developmental programs, relying on a level of 
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biological plasticity rarely seen in animals. “Escape” for a plant requires the capability to 
recognize a hazard, an extant strategy to cope with the hazard, and the flexibility to change its 
own growth patterns to enact that strategy. 
That flexibility in biological response is a central theme of the work described in this 
thesis. Specifically, we study the methods plants use to sense and respond to signals from within 
and without the plant. This requires recognition 
and integration of inputs, transport of molecular 
intermediaries of the signal through the cell, and 
the translation of the abundance of those 
intermediates into a low-level biological change 
that can affect the behavior of the cell. I will be 
discussing hormone signaling, and the hormone 
of interest to our research group is cytokinin. 
Cytokinins are a class of molecules capable of 
interacting with and activating the receptor 
proteins of the cytokinin signaling pathway 
(Figure 1.1) (Romanov et al., 2006; Stolz et al., 
2011; Lomin et al., 2015). They regulate a broad, 
diverse set of biological processes, including, 
among others, organ formation, leaf expansion, 
senescence timing, control of apical dominance, nutrient distribution and uptake, cell 
proliferation, nodulation, environmental stress responses, plant pathogen responses, and 
Figure 1.1. Cytokinin signaling in Arabidopsis thaliana.  
Cytokinin is perceived in the ER lumen, which causes the 
AHKs to undergo a phosphorylation event. The phosphoryl 
group is transferred to the AHPs, which then transfer the 
phosphoryl group to either a type-A or type-B ARR in the 
nucleus. Type-A ARRs act to negatively regulate the 
pathway through an unknown mechanism and are 
transcriptionally responsive to cytokinin signaling. Type-B 
ARRs act as transcription factors but are largely not 
responsive to cytokinin signaling. 
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chloroplast development (Mok and Mok, 2001; Argueso et al., 2010; Hwang et al., 2012; Kieber 
and Schaller, 2014).  
Trans-zeatin biosynthesis in Arabidopsis begins with either ATP or ADP, which is 
converted to iPRTP/iPRDP with the addition of an isoprene side chain by one of several IPT 
enzymes (Takei et al., 2004). The side chain of isopentenyl adenine is hydroxylated by 
CYP735A to form trans-zeatin ribotide, which is then converted to the free base form by the 
LONELY GUY (LOG) family of enzymes (Kurakawa et al., 2007; Kuroha et al., 2009; 
Tokunaga et al., 2012). Trans-zeatin molecules typically are broken down by oxidation by 
CYTOKININ OXIDASE (CKX) proteins (Schmülling et al., 2003; Kowalska et al., 2010) or 
modified by glucosyltransferases for storage or degradation (Brzobohatý et al., 1993; Hou et al., 
2004). Cytokinin is transported distally in the plant as ribosides (Matsumoto-Kitano et al., 2008; 
Kudo et al., 2010), which are then converted to their active form inside the cell by LOG proteins. 
Cytokinin was first identified as an unknown compound in coconut milk capable of 
promoting growth in embryonic and somatic tissue in a variety of plant species (Overbeek et al., 
1941; Ball, 1946; Caplin and Steward, 1948; Nickell, 1950; Morel and Wetmore, 1951; Steward 
and Caplin, 1951; Mauney et al., 1952; Miller C.O. et al., 1956). Similar growth-promoting 
activity was later identified in yeast extracts and autoclaved salmon sperm , leading to the 
identification of kinetin, a derivative of adenine (Miller C.O. et al., 1956). A class of chemicals, 
kinins, later re-named cytokinins, was also defined (Hall, 1873; Miller C.O. et al., 1956). Other 
cytokinins discovered since include zeatin (Letham, 1963), isopentenyl adenine (Dyson and Hall, 
1972), and benzyladenine (BA) (Hamzi and Skoog, 1963). In Arabidopsis, the highest receptor 




The cytokinin signaling pathway in Arabidopsis is similar to bacterial two-component 
signaling systems and was identified by comparisons of Arabidopsis proteins to bacterial TCS 
proteins (Perraud et al., 1999; Stock et al., 2000; West and Stock, 2001; Mizuno, 2005; Schaller 
et al., 2008). In a prototypical bacterial two-component signaling system, a sensor histidine 
kinase detects undergoes a phosphorylation event in response to stimulus, the kinase transfers its 
phosphoryl group through a His-to-Asp phosphorelay to a response regulator, and the response 
regulator mediates the signaling output of the pathway. The Arabidopsis incarnation of this 
pathway is an extended form that incorporates a phosphorelay step (Swanson et al., 1994; 
Appleby et al., 1996; Schaller et al., 2011). In this form, cytokinin is perceived by the 
ARABIDOPSIS HISTIDINE-CONTAINING KINASE (AHK) proteins. Three AHK genes have 
been shown to contribute to cytokinin signaling: CYTOKININ RESPONSE 1 (CRE1) / AHK2, 
AHK3, and WOODEN LEG (WOL) / AHK4 (Scheres et al., 1995; Mahonen et al., 2000; Inoue 
et al., 2001; Ueguchi et al., 2001a; Yamada et al., 2001). The AHKs consist of a 
Cyclases/Histidine Kinases Associated Sensor Extracellular domain (CHASE domain) linked to 
a histidine kinase domain and a receiver domain (Anantharaman and Aravind, 2001; Inoue et al., 
2001; Heyl et al., 2007; Hothorn et al., 2011). Following binding by cytokinin in the lumen of 
the ER (Yamada et al., 2001; Romanov et al., 2006; Caesar et al., 2011; Lomin et al., 2011; Stolz 
et al., 2011; Wulfetange et al., 2011), the histidine kinase domain undergoes an 
autophosphorylation event, and then the phosphoryl group is transferred to a receiver domain at 
the C terminus of the protein (Hutchison and Kieber, 2002). The AHKs also possess phosphatase 
activity in the absence of cytokinin binding to the CHASE domain (Mähönen et al., 2006). 
 Phosphoryl groups from the AHKs are transferred to the ARABIDOPSIS HISTIDINE-
CONTAINING PHOSPHOTRANSFER (AHP) proteins. Six genes have been identified in 
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Arabidopsis: AHP1 through AHP6. The first five true AHPs were first identified by the presence 
of a histidine phosphotransfer (HPt) domain in five separate genes (Miyata et al., 1998; Suzuki et 
al., 1998; Initiative, 2000; Suzuki et al., 2000; Schaller et al., 2008) and a sixth, pseudo-AHP 
(PHP) incapable of being phosphorylated by the AHKs has also been identified (Mahonen et al., 
2006). The AHPs physically interact with both the AHKs and the ARRs (Urao et al., 1998; 
Imamura et al., 1999; Tanaka et al., 2004; Dortay et al., 2006) and function by accepting 
phosphoryl groups from the AHKs and transferring the phosphoryl group to the ARRs (Suzuki et 
al., 1998; Hutchison et al., 2006; Deng et al., 2010; Cheng et al., 2013). The AHP6 protein lacks 
the conserved His site that serves as the phosphorylation carrier and thus cannot participate in 
phosphorelay-based cytokinin signaling (Mahonen et al., 2006). Genetically, it has been shown 
to inhibit cytokinin signaling and to play a role in the patterning of the vasculature of roots in 
Arabidopsis (Mahonen et al., 2006; Bishopp et al., 2011). 
The phosphorylated AHPs interact with ARABIDOPSIS RESPONSE REGULATOR 
(ARR) proteins. These proteins come in two main classes, type-B and type-A ARRs. The type-A 
ARR genes are ARR3 through ARR9 and ARR15 through ARR17, and the type-B ARRs are ARR1, 
ARR2, ARR10 through ARR14, and ARR18 through ARR21. The first class discussed here, the 
type-B ARRs, mediate the transcriptional output and downstream biological changes in response 
to cytokinin. Type-B ARRs were first identified by the presence of their RR domains 
(Brandstatter and Kieber, 1998; Imamura et al., 1998; Suzuki et al., 1998; Urao et al., 1998) and 
later identified as DNA-binding transcription factors (Sakai et al., 1998; Imamura et al., 1999; 
Lohrmann et al., 1999; Sakai et al., 2000; Hosoda et al., 2002; Imamura et al., 2003) and are 
primarily localized in the nucleus (Lohrmann et al., 1999; Imamura et al., 2001; Lohrmann et al., 
2001; Hosoda et al., 2002). The principal type-B ARRs in Arabidopsis mediating cytokinin 
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signaling are ARR1, ARR10, and ARR12 (Mason et al., 2005; Yokoyama et al., 2007; Argyros et 
al., 2008; Ishida et al., 2008). 
The second class of ARRs is the type-A ARRs (D’Agostino et al., 2000; Schaller et al., 
2008). Like the type-Bs, these proteins have a receiver domain and interact with the AHPs, but 
lack a DNA-binding domain (Imamura et al., 1998; D’Agostino and Kieber, 1999b; Hutchison 
and Kieber, 2002; Dortay et al., 2006; Schaller et al., 2008). Response regulators have been 
observed to interact with regulatory proteins in a phospho-dependent manner in other species for 
control of protein-protein interactions or sub-cellular localization (Jenal and Galperin, 2009), and 
have been observed in the same role in Arabidopsis, where the type-As are negative regulators of 
cytokinin signaling (Kiba et al., 2003; To et al., 2004; Leibfried et al., 2005; Lee et al., 2007a; To 
et al., 2007) and are transcriptionally upregulated following cytokinin signaling (Brandstatter and 
Kieber, 1998; Taniguchi et al., 1998; D’Agostino et al., 2000; Taniguchi et al., 2007; Xie et al., 
2018). While the molecular mechanism for the negative regulation is unknown, several methods 
for negative regulation of cytokinin signaling by the type-A ARRs have been hypothesized. The 
most straightforward proposal is that they act as phosphate sinks, similar to some bacterial two-
component systems such as CheA/CheY chemotaxis system in E. coli (Sourjik and Schmitt, 
1998; Dortay et al., 2006). The type-As and type-Bs both undergo a phosphotransfer reaction 
with the AHPs, but only the type-As are upregulated by cytokinin treatment (Brandstatter and 
Kieber, 1998; Taniguchi et al., 1998; D’Agostino et al., 2000; Taniguchi et al., 2007). If more 
type-A ARRs are present than type-Bs, then more phosphoryl groups will be transferred to them 
rather than to the type-Bs, and thus  there will be a reduction in the number of activated type-B 
ARRs. As a subset of type-A ARRs are stabilized by phosphorylation (To et al., 2007), the 
phosphorylation intercepted by the newly synthesized type-A ARRs would also further increase 
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their negative regulatory effect. However, a phosphomimic mutant type-A ARR can partially 
rescue a multiple type-A loss of function mutant (To et al., 2007). The phosphomimic protein 
replaces the conserved aspartic acid residue that receives the phosphoryl group from the AHPs 
with a glutamic acid (Kurepa et al., 2014). The glutamic acid is not phosphorylated, but has a 
chemical character similar enough to a phosphorylated aspartic acid that it can partially mimic a 
phosphorylated wild type ARR (Hass et al., 2004). If a phosphate sink mechanism were solely 
responsible, a phosphomimic protein would not rescue a loss-of-function mutant. However, 
phosphate sink activity may play at least some role in the negative regulation of type-A ARRs, as 
the relative abundance of the type-As does increase with cytokinin signaling increases. However, 
sink activity could be negligible. For example, if the binding affinity of phosphorylated AHPs 
with type-B ARRs is higher than for type-A ARRs, then the phosphate sink effect of increased 
type-A ARR prevalence would be muted. Sink activity alone may serve to extend flux through 
the cytokinin pathway rather than dampen it. In bacterial systems, phosphotransfer in two 
component systems has been shown to be reversible in some cases (Stewart, 1997; Zapf et al., 
2000). If reversible phosphotransfer occurs in Arabidopsis, phosphoryl groups on Type-As could 
transfer back to the AHPs and then to the type-B ARRs.  It has also been suggested that 
increased abundance of type-A ARRs could bind to and effectively sequester AHPs, preventing 
them from binding to other proteins such as the AHKs (Dortay et al., 2006). Another proposed 
mechanism similar to the phosphate sink concept is that type-A ARRs could dephosphorylate 
phosphorylated AHPs (Imamura et al., 1998; Suzuki et al., 1998; Dortay et al., 2006). This 
would be effectively a phosphate sink but by a different mechanism as the phosphates are “sunk” 
into the cytoplasm rather than onto the type-A ARRs.  Three ARRs (ARR3, ARR4, and ARR22) 
were shown to have phosphohistidine phosphatase activity toward the AHPs (Imamura et al., 
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1998; Kiba et al., 2004; Horák et al., 2008). However, the presence or extent of phosphatase 
activity in other ARRs has not been documented in the literature, so the relative contribution of 
this mechanism is unknown. 
Other mechanisms for negative regulation of cytokinin signaling that do not rely on the 
type-As have been proposed or documented. For example, the CKX genes which degrade 
cytokinins are transcriptionally upregulated in response to exogenous cytokinin (Werner et al., 
2003; Taniguchi et al., 2007; Bhargava et al., 2013). This transcriptional response results in an 
increase in the number of cytokinin-degrading enzymes in the cell, reducing the abundance of 
active cytokinin molecules faster than normal cytokinin movement and natural 
dephosphorylation would otherwise.  Additionally, there may be phospho-dependent interaction 
with cytokinin signaling regulators.  
There may be other regulators of cytokinin signaling. It has been proposed that there may 
be distinct phosphatases to inactivate type-B ARRs (Kiba et al., 2004; Horák et al., 2008). 
Auxiliary phosphatases have been observed in several bacterial two component systems (Perego 
et al., 1996; Silversmith, 2010) so there may be uncharacterized auxiliary phosphatases in the 
Arabidopsis genome as well. The type-B ARRs are regulated by the KISS ME DEADLY (KMD) 
proteins through targeting of E3 ligases (Kim et al., 2013b; Kim et al., 2013a; Zheng and 
Shabek, 2017), although others have suggested that KMD protein regulation of cytokinin 
signaling may be a downstream effect of regulation of phenylpropanoid synthesis resulting in 
altered auxin sensitivity (Kurepa et al., 2018). The Gα EXTRA-LARGE G PROTEIN (XLG) 
proteins have been shown to interact with E3 ligases to regulate cytokinin signaling through 
degradation of ARR10 (Wang et al., 2017). It is not known whether ubiquitination-mediated 
degradation is a factor in the regulation of any other cytokinin signaling proteins. Negative 
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regulation is also accomplished through nitrous oxide (NO). NO regulation of cytokinin 
signaling has been observed for AHP1 where NO molecules covalently modify a cysteine 
residue and disrupt phosphotransfer reactions (Feng et al., 2013). 
My thesis studies focused on two areas of research. The first goal was to identify 
uncharacterized genes involved in cytokinin signaling. To that end, I performed a sensitized 
genetic screen for enhancers of ahp (eah) mutants which are hyposensitive to exogenously 
supplied cytokinin. This eah screen identified several new alleles of ahk4, one of the cytokinin 
receptors in Arabidopsis, as well as implicating the light-signaling transcription factor hy5. It 
also has identified a number of additional genes that have yet to be identified that are not in 
known targets. 
The second goal was developed over the course of pursuing the first goal, and that was to 
develop tools to overcome obstacles I encountered in my own research that I anticipated would 
be useful resources for other scientists. As part of the eah screen, we developed the 
“mutagenomics” strategy for cloning uncharacterized mutants in a screen. Mutagenomics is 
discussed at length in Chapter 2. We believe the strategies developed during the completion of 
the screen have the potential to accelerate the pace of genetic screens in plant biology. I also 
developed a primer design tool, indCAPS, to aid the search for novel CRISPR/Cas9-derived 
mutant alleles. The indCAPS project is described in Chapter 4. It is designed to be used for 
Cleaved Amplified Polymorphic Sequence (CAPS) or derived CAPS (dCAPS) restriction-digest 







CHAPTER 2: MUTAGENOMICS: A HIGH-THROUGHPUT METHOD TO IDENTIFY 
CAUSATIVE MUTATIONS FROM A GENETIC SCREEN 
 
Introduction 
A wide variety of genetic screens have been used to dissect numerous biological 
processes, helping to define the elements involved as well as their roles in various pathways 
(Forsburg, 2002; Page and Grossniklaus, 2002; St Johnston, 2002; Candela and Hake, 2008). The 
most common approach utilized is to screen a population of randomly mutagenized lines for a 
phenotype of interest and to subsequently identify the genes corresponding to these mutations. 
Generating T-DNA or other insertional alleles simplifies subsequent cloning of the mutated 
genes, but limits the breadth of allelic diversity obtained, and it is tedious to generate such 
populations in desired genetic backgrounds. Chemical mutagens, such as ethyl methanesulfonate 
(EMS), that induce point mutations facilitate the creation of large mutagenized populations in 
nearly any genetic background and generate a large diversity of alleles; however, cloning the 
causative genes from such alleles is much more technically challenging. Diverse methods exist 
for these purposes, but most rely on marker-based mapping procedures. To this end, an outcross 
is performed between a mutant line of interest with a second line harboring numerous genomic 
variants, most commonly small nucleotide polymorphisms (SNPs). The F2 population from the 
cross is collected, and the co-segregation of the phenotype of interest with molecular markers is 
determined. With sufficient marker density, an interval defining the genomic region containing 
the targeted mutation can be deduced and the causative gene confirmed by genetic 
complementation or analysis of independent alleles.  
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The use of next generation high throughput sequencing technologies and experimental 
approaches that leverage bulked segregant mapping have greatly facilitated the process of 
cloning genes corresponding to point mutations (Michelmore et al., 1991). Variations of this 
include NGM (Austin et al., 2011),  SIMPLE (Wachsman et al., 2017), CloudMap (Austin et al., 
2011), the SHOREmap pipeline (Schneeberger et al., 2009), MutMap+ (Fekih et al., 2013), and 
NIKS (Nordström et al., 2013). Typically, these pipelines rely on segregation of SNPs (derived 
from sequence variations of a distinct parental ecotype or the numerous random SNPs induced 
by EMS mutagenesis) derived from an outcross. Comparisons of SNP frequencies between 
homozygous mutant lines and reference lines reveal regions of the genome linked to the 
causative mutation. Simulations for the effect of increasing the number of F2 segregants pooled 
from this analysis indicate that at least 40 segregants may be required to generate fewer than 20 
candidate genes (Velikkakam James et al., 2013). While powerful, these methods are laborious 
and, consequently, only a small subset of lines are analyzed from a screen. 
The plant hormone cytokinin regulates a diverse set of biological processes in plants, 
including shoot formation, meristem activity, nutrient uptake, various abiotic and biotic 
interactions, and multiple developmental pathways (Kieber and Schaller, 2014). Cytokinin binds 
to histidine kinase receptors (AHKs) (Inoue et al., 2001; Ueguchi et al., 2001b; Yamada et al., 
2001; Caesar et al., 2011; Wulfetange et al., 2011) which autophosphorylate on a His within the 
histidine kinase domain and then shuttle the phosphate to an Asp residue within the fused 
receiver domain of the AHK. This phosphate is subsequently passed to a histidine 
phosphotransfer protein (AHPs) (Miyata et al., 1998; Suzuki et al., 1998; Imamura et al., 1999; 
Hutchison et al., 2006; Schaller et al., 2008), which in turn transfer it to a type A- or type B-
Response Regulators (ARRs) (To et al., 2004; Mason et al., 2005; To et al., 2007). 
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Phosphorylation of the type-B RRs activates these transcription factors, which bind to their 
genomic targets to regulate the primary wave of cytokinin-regulated transcriptional changes 
(Mason et al., 2005; Argyros et al., 2008; Zubo et al., 2017), which includes the type A-ARRs 
(Brandstatter and Kieber, 1998; Taniguchi et al., 1998; D’Agostino et al., 2000; Taniguchi et al., 
2007). Type-A ARRs negatively regulate the signaling pathway, acting as feedback regulators to 
dampen the response to cytokinin (Kiba et al., 2003; To et al., 2004; Leibfried et al., 2005; Lee et 
al., 2007a; To et al., 2007).  
Here, we performed a genetic screen on an Arabidopsis line genetically sensitized to 
perturbation of cytokinin responsiveness to search for novel elements involved in the response to 
cytokinin. To analyze the output from this screen in an unbiased way, we developed a pipeline to 
identify multiple causative mutations in a parallel manner, which we call “mutagenomics”. In 
additional to multiple alleles of the AHK4 receptor, the ethylene signaling element EIN2, and 
AUX1, we identified HY5 as an important mediator of cytokinin responsiveness. Further analysis 
revealed that HY5 was necessary for a subset of the transcriptional response to cytokinin. The 
mutagenomics strategy described here is a powerful tool for researchers performing mutant 
screens. It is species-agnostic, although it is especially useful in self-fertilizing model organisms. 
Mutagenomics has the potential to accelerate the pace of discovery of novel genes by greatly 








Identification of mutants affected in the response to cytokinin using a sensitized genetic 
screen. 
While prior analysis has defined a cytokinin response pathway from perception of 
cytokinin by the AHK receptors through phosphorylation and activation of transcription factors, 
it is likely that additional elements involved in the response to this phytohormone remain to be 
identified. One challenge with identifying mutations in genetic screens is that the effects of these 
alterations on the process being analyzed may be subtle, due to genetic redundancy, or 
alternatively, null alleles may be lethal for some genes due to pleiotropy and thus only 
hypomorphic alleles may be recoverable. This is particularly true for a well-characterized 
pathway such as cytokinin signaling, in which the most straightforward genes have already been 
identified (Kieber and Schaller, 2014). To exhaustively screen for genes involved in the response 
to cytokinin, we EMS mutagenized an Arabidopsis line that is partially compromised for 
cytokinin signaling due to loss-of-function mutations in ahp2 and ahp3. This double ahp2,3 
mutant has comparable cytokinin sensitivity to the wild type in a root elongation assay, as does 
the single ahp1 mutant (Figure 2.1A) (Hutchison et al., 2006). In contrast, the ahp1,2,3 triple 
mutant is partially resistant to cytokinin, suggesting the double mutantis a genetically sensitized 
to modest perturbations of cytokinin responsiveness. Using a root elongation assay, we 
determined that 0.1 µM 6-benzyleaminopurine (BA), a synthetic cytokinin, resulted in a 
substantial, easily scored difference in root length between the ahp2,3 and ahp1,2,3 lines, but 
was not saturating for the response, indicating that this is a suitable condition to detect subtle 




Figure 2.1. Genetic screen for cytokinin hyposensitivity. We employed an ahp2,3 double mutant as a sensitized parent for a 
genetic screen of mutants altered in the response to cytokinin. A) Root elongation assay to determine the optimal concentration of 
benzyl adenine (BA) to use for the screen. Seedlings of the indicated genotypes were grown for three days on control media and 
then moved to media containing the indicated level of BA. The growth between 3 and 8 days after germination (DAG) was 
quantified. B) Representative images of wild type (Col) and the indicated mutants, including a representative eah line (eah24), 
grown as in (A). C) Flow chart describing the details of the genetic screen. D) Histogram of number of protein-altering (PA) 
SNP densities in sequenced mutant lines. PA-SNPs are inferred using SnpEff and consist of all mutations causing missense, 
nonsense, or splice site mutations 
We mutagenized an ahp2,3 line and screened for altered sensitivity to cytokinin using 
these conditions. Approximately 750,000 Arabidopsis seeds were mutagenized with EMS, the 
resultant M1 plants grown to maturity and M2 seeds harvested in 111 pools, with a mean pool 
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size of 140 plants per pool (Figure 2.1C). An initial 1,200 putative mutants were identified from 
this population, which were refined to 272 strongly hyposensitive mutants from 78 independent 
pools after re-screening M3 seedlings. A representative mutant is shown in Figure 2.1B. We 
refer to these mutations as enhancer of AHPs (eah). Mutants disrupted in ethylene signaling 
would also be identified in this screen as exogenous cytokinin inhibits root elongation via 
elevated ethylene biosynthesis (Vogel et al., 1998).  To identify these ethylene-hyposensitive 
lines, we assessed the sensitivity of the eah lines to ethylene using a triple response screen (Table 
2.1) (Guzman and Ecker, 1990). We removed most of the ethylene-insensitive eah lines from 
further consideration, though we continued to analyze nine as a proof of concept for the 













Table 2.1. eah mutant lines analyzed by mutagenomics. 
1Sibling group for eah14. 
2Sibling group for eah22. 
3Indicates all PA-SNPs called by GATK and SnpEff, regardless of zygosity. 
4ACC response: S; Sensitive, I; Insensitive, w; weakly insensitive, nd; not determined 
5F1 failure to complement in cross with cre1-12. 















Splice acceptor variant 
c.1708-1G>A 
S 
eah125 653 172 86 AHK4 Thr1034Ile S 
eah14-11,5 153 20 14 AHK4 Gln928* S 
eah14-21 125 27 11 AHK4 Gln928* S 
eah155 565 137 79 AHK4 Asp1036Asn w 
eah175 200 34 26 AHK4 Ser142Asn S 
eah255 586 171 109 AHK4 Gly139Arg w 
eah32 427 106 55 AHK4 Ser142Asn S 
eah34 168 46 42 AHK4 Trp753* nd 
eah45 779 223 118 AHK4 Thr486Ile S 









eah13 479 139 75 AHK4 Trp134* S 
eah22-12 129 21 10 HY5 c.439-1G>A S 
eah22-22 130 25 16 HY5 c.439-1G>A S 









eah4 385 89 47 EIN2 Pro460Leu I 
eah6 335 70 41 EIN2 Gly247Arg I 
eah10 307 68 45 EIN2 Leu375Phe I 
eah18 531 132 35 EIN2 Trp1012* I 
eah21 429 103 76 EIN2 Trp1158* I 
eah47 401 105 51 EIN2 Gly882Glu S 









eah30 511 140 59 CKI1 Pro289Ser S 
eah31 304 86 50 ARR3 Ala140Val S 
eah39 372 83 62 ARR12 Pro538Ser S 
eah24 268 63 33 AHK3 Trp801* nd 
eah5 563 163 99   w 
eah7 300 72 34   I 




17-125 15 independent eah lines with no 





12-107 6 independent eah lines with no 




 To identify the causative mutations in the eah lines, we developed the mutagenomics 
pipeline, summarized in Figure 2. For this approach, the genomic sequences of a large subset of 
the mutant lines were determined, with the goal of identifying all the predicted protein-altering 
(PA) SNPs in each line. We identified M3 progeny that were homozygous for the eah phenotype 
and determined the sequence of their genomes using high throughput Illumina sequencing. We 
sequenced each mutant line to a target read depth of at least 20x coverage. In addition, we 
sequenced non-mutagenized ahp2,3 plants from the same seed stock used for mutagenesis. Any 
background SNPs present in the pre-mutagenesis stock would be identified when mutants are 
sequenced, but they are not causative for the novel mutant phenotypes. Cataloguing the 
background mutations permits filtering those SNPs from final SNP calls for each mutant, 
restricting the SNPs in consideration to only those introduced by the mutagenesis process. A 
total of 1,825 background SNPS (relative to TAIR10) were observed in the ahp2,3 background. 
In addition to background SNPs, we found that there was an average of 144 PA-SNPs per mutant 
line (both homozygous and heterozygous), ranging from as few as 20 to as many as 223 (Table 
2.1; Figure 2.1D). When one considers only homozygous PA-SNPs, there are on average 57 per 
line, ranging from 11-125 per line. This is consistent with previous analyses of EMS-
mutagenized Arabidopsis that found 100-200 PA-SNPs per line (Thole et al., 2014). This 
sequence information was used to sequentially analyze the lines with a three-step pipeline 
(Figure 2.2). In the first step, lines with PA-SNPs in genes known to be involved in the process 
of interest are identified. For example, in the case of the eah screen, we screened for genes 
previously identified that might, in combination with ahp2,3, result in an elongated root in the 
presence of exogenous cytokinin, such as AHK4 (Inoue et al. 2001; Higuchi et al 2004). Lines 
that do not harbor mutations in the screened known targets then progress to step two of 
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mutagenomics. In this second step, genes that are found in multiple lines with PA-SNPs are 
identified. The idea is that if a gene is found mutated in multiple independent lines, then it is 
likely to be causative for the phenotype being screened for. In step three, to identify the causative 
mutations in the remaining lines, multiple lines from the same pool (likely siblings) are analyzed 
for overlapping homozygous PA-SNPs to narrow the candidate gene list down to a small 
number. As described below, we successfully applied mutagenomics to the eah screen as a proof 





Figure 2.2 Overview of the mutagenomics process. Top) Implementing mutagenomics is a multi-stop process that starts with a 
collection of mutant lines with unknown causative mutations. Middle) A number of lines are re-sequenced to detect mutations in 
known genes. Lines with no mutations in known genes can be prioritized in later stages. Bottom Right) Independent lines are 
examined to determine whether any genes are mutated in multiple independent lines more frequently than would be expected by 
chance alone. Bottom Left) Additional mutants from the same pool as previously-sequenced mutants can be re-sequenced to find 
lines of common descent (sibling lines). Sibling lines will share a subset of mutations between them, and this subset is examined 








Mutagenomics applied to the eah screen 
Step 1: Screening for mutations in genes known to affect cytokinin responsiveness. 
After re-testing and removing most ethylene-insensitive lines, we distilled our eah screen 
to 53 lines that we subjected to mutagenomics (Table 2.1). In the first step, we sought to identify 
lines harboring mutations in genes that have been previously linked to cytokinin sensitivity 
(Table S1). We screened the genomic sequences of the eah lines for PA-SNPs in these genes. We 
identified 13 alleles of ahk4 in the eah screen (Table 2.1). AHK4 encodes a cytokinin receptor 
and is the predominant member acting in the root response to cytokinin of the three Arabidopsis 
cytokinin receptors (Higuchi et al., 2004; Nishimura et al., 2004; Riefler et al., 2006). AHK4 has 
a cytoplasmic N-terminal domain, an ER-localized cytokinin-binding CHASE domain, and 
cytosolic kinase and receiver domains. We identified eight missense alleles in ahk4, four 
nonsense alleles, and one allele predicted to alter a splice site (Figure 2.3A). We confirmed that 
the causative mutations in a subset of these lines were indeed ahk4 alleles by complementation 
tests with the cre1-4 allele of AHK4 (Table 2.1). Four of the eah missense mutations were 
predicted to alter residues within the transmembrane domains of AHK4. Remarkably, this 
includes two identical missense mutations (S142N) that were isolated from independent pools. 
These lines (eah17 and eah32) were confirmed to be independent alleles as they did not share 
any SNPs throughout the genome other than S142N. Two missense mutations were predicted to 
alter residues within the His kinase domain, consistent with the observation that histidine kinase 
activity is required for cytokinin signaling (Mähönen et al., 2006). Finally, three of the mutations 
are predicted to alter residues within the receiver domain (Figure 2.3A). Two of these (D996N 
and T1034I) are annotated as part of the active site (Lin et al., 1999).. The Asp at position 996 is, 
in fact, the target Asp that accepts the phosphate group from the HK domain and has been 
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previously demonstrated to be essential for AHK4 function (Inoue et al., 2001; Mähönen et al., 
2006). A third missense mutation, D1036N, is two residues away from? an active site residue on 
the AHK4 primary amino acid sequence. To examine the predicted effect of these missense 
alleles, the AHK4 receiver domain was modeled using the hhpred software suite (Zimmermann 
et al., 2018) and modeled in pymol (Figure 2.3B). Examination of the predicted 3D structure 
shows the D1036 residue is physically near the active site residues, similar to the D996 and 
T1034 residues, but further toward the outer surface of the domain.  
 
Figure 2.3. Disruptive and missense mutations were observed in AHK4. A) Gene model of AHK4 showing the position and 
character of mutations in AHK4 identified in this screen. TM1 and TM2 (brown) are the transmembrane domains; CHASE 
domain (green); His kinase domain (blue); REC-like (orange) and REC (purple) are the receiver-like and receiver domains; 
UTRs (gray). The red D996N mutation is the second D in the conserved DDK motif (Mahonen et al., 2006) that is the conserved 
phosphorylation site for the receiver domain. B) Computationally predicted model of the AHK4 receiver domain. The three 
mutated residues in this domain are shown in green. 
 
We also identified mutations in other two-component signaling elements in the eah 
screen. The eah24 mutant harbors a nonsense allele in the coding region of AHK3, which 
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encodes a second cytokinin receptor that plays a more minor role in cytokinin responses in the 
root (Higuchi et al., 2004; Nishimura et al., 2004). Single ahk2 mutations do not significantly 
affect the response to exogenous cytokinin in root elongations assays (Higuchi et al., 2004; 
Nishimura et al., 2004) and so it is likely that the cytokinin hyposensitivity in this eah30 line 
reflects the sensitized nature of the ahp2,3 parental line. We also identified mutations in CKI1, 
which encodes a histidine kinase that lacks the cytokinin-binding CHASE domain (Kakimoto, 
1996). Various lines of evidence suggest that CKI1 can activate downstream cytokinin signaling 
to regulate vascular and gametophytic development, though it lacks a CHASE domain and thus 
its activity is not regulated by cytokinin binding (Kakimoto, 1996; Hwang and Sheen, 2001; 
Pischke et al., 2002; Hejátko et al., 2009; Yuan et al., 2016). Null alleles of cki1 are lethal 
(Pischke et al., 2002). It is possible that this eah30 allele of cki1 decreases input into cytokinin 
signaling sufficiently in an ahp2,3 background to confer cytokinin hyposensitivity, though it is 
also plausible that this is not the causative mutation for the cytokinin response phenotype in this 
line. Finally, we identified two lines with mutations in type-B ARRs. In eah39, there is a 
mutation in ARR12; single arr12 mutants display a modest hyposensitivity to cytokinin in root 
elongations assays (Mason et al., 2005), and this may act additively with the ahp2,3 mutations. 
In line eah41 there is a mutation in ARR13, as well as a second mutation in AHK4; it is likely 
that the ahk4 mutation is the primary driver of cytokinin hyposensitivity in this line. 
Of the eah lines that we analyzed, eight of them displayed a strong ethylene-insensitive 
phenotype as measured by a triple response assay (Table 2.1). Six of these are in the previously 
identified EIN2 gene. One line with an ein2 mutation (eah47) was fully sensitive to ethylene in a 
triple response assay, suggesting either that it is not the causative mutation for the cytokinin 
hyposensitive phenotype, or that this allele of ein2 affects root elongation in the light, but not the 
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triple response in etiolated seedlings. Conversely, one line (eah3) with an ein2 mutation had a 
weak ethylene-insensitive phenotype; eah3 also had an ahk4 mutation that was confirmed by a 
complementation test with cre1-4. Intriguingly, three eah lines that displayed an ethylene-
insensitive phenotype did not display PA-SNPs in any of the screened ethylene-related candidate 
genes (Table S1; note that the eah46 also had an ahk4 mutation), suggesting that they may affect 
novel elements in the response to ethylene. 
Mutagenomics step 2: Screening for potential causative mutations identified by multiple 
independent alleles. 
 The second step in the mutagenomics pipeline involves identifying genes that are found 
to be mutated in multiple independent lines, above what one would predict by chance. To 
ascertain the probability of finding any gene mutated in multiple lines randomly, we performed 
simulation modeling to define the probability of finding independently derived mutations with an 
increasing number of lines analyzed (Figure 2.4A). The simulations were performed using the 
average density of homozygous protein-altering SNPs observed in the eah screen and used 
previously reported estimates of crossover frequencies with the zero-crossover and one-crossover 
categories merged (Salomé et al., 2012). Statistically, the frequency of finding multiple 
independent alleles of a gene in a random population of mutant lines is fairly high (Figure 2.4A). 
For example, if one is analyzing 50 independent mutant lines, the probability of finding at least 
one gene that was mutated by chance four times is >90%, and five times ~25%. The actual rate at 
which any gene is mutated is dependent on multiple factors, including target size (including both 




Figure 2.4. Inference of over-enriched mutations in independent mutant lines. Simulation-derived probability of at least one 
occurrence of m independent alleles in any gene in n independent mutant lines. Different curves represent different numbers of 
independent alleles. The blue line shows 3 independent alleles; the red line 4 alleles; and the green line 5 alleles. 
Consistent with our simulation studies, we find many genes that are independently 
mutated at least two to four times from our pool of 53 eah lines (Figure S1). As there is a 
reasonable probability (~25%) that even five  independent alleles would be recovered by chance 
(Figure 4), we searched for genes identified as being mutated in at least six independent lines as 
these are highly likely to be causative mutations. The only two genes identified with at least six 
lines harboring homozygous PA-SNPs in the same gene (i.e. independent alleles) are ein2 (8 
alleles) and ahk4 (13 alleles). In screens for ethylene-insensitivity, ein2 is the most frequently 
identified mutation, presumably reflecting its large size (encoded protein is 1,294 amino acids), 
non-redundant nature, and strong phenotype (Alonso et al., 1999). Likewise, AHK4 is a large 
gene (encoded protein is 1,080 amino acids) and ahk4 loss-of-function mutations are known to 
confer a strong cytokinin-hyposensitive phenotype in root elongations assays (Higuchi et al., 
2004; Nishimura et al., 2004; Riefler et al., 2006). As noted, the eah3 line harbors both ein2 and 
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ahk4 mutations. As this line both has a weak ethylene-insensitive phenotype and fails to 
complement cre1-4, it is likely a double loss-of-function ein2 ahk4 mutant. 
Mutagenomics step 3: Analysis of lines of common descent to narrow down candidate 
genes.  
In the first two steps of mutagenomics, we identified genes that were previously 
implicated in cytokinin signaling and/or which are represented by more than six independent 
alleles in our mutant pool. Twenty-seven lines remain (out the original 53 analyzed) for which a 
causative gene was yet not identified. For these, we have developed a third step in the 
mutagenomics pipeline to substantially narrow down the number of potential candidate genes. 
This step involves sequencing additional lines that are derived from the same pool as the targeted 
mutant; these will generally be sibling mutants harboring the same causative mutation (if the 
pool size is sufficiently small, < 100 lines). The basic idea is that, as you sequence increasing 
numbers of homozygous sibling lines, you continually enrich for the homozygous causative 
mutation as the other non-relevant PA-SNPs randomly segregate.  
To further develop the theoretical underpinnings of this step, we performed a series of 
simulation experiments to estimate the number of overlapping homozygous PA-SNPs expected 
in comparisons of two to six M3 siblings. The M3 generation was simulated rather than the M2 
in order to emulate a typical screen in which M2 individuals are identified and retested in the M3 
generation to confirm the phenotype of interest. For this analysis, we used PA-SNP densities 
ranging from 10 to 285 per line, consistent with the observed numbers per line in our screen 
(Figure 2.1D). The PA-SNPs were randomly allocated across the genome and allowed to 
segregate independently. If a mutation was identified as homozygous in all lines, this was added 
to the number of candidate genes for that trial. This process was repeated for 10,000 trials to 
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estimate the degree of overlap observed between siblings. The simulation experiments are 
summarized in Figure 5. A striking prediction from this analysis is that even for a line with 285 
PA-SNPs, sequence analysis of as few as four additional siblings reduces the number of 
candidate genes to fewer than five, which is a very manageable number for subsequent analysis. 
With lines containing fewer PA-SNPs, this is reduced to even fewer candidates.  
 
Figure 2.5. Projected numbers of shared alleles between M3 siblings. Bars indicate the mean and standard deviation of 
simulation-derived distributions of mutations shared between sibling lines. The gray bar indicates 5 genes. The range of M3 PA-
SNP densities is representative of the number of PA-SNPs observed in the eah screen. 
 
As a proof of concept, we sequenced a pair of siblings from the eah14 mutant line 
(eah14-1 and eah14-2). Note that AHK4 was already identified as a causative mutation in the line 
from both step one and two of the mutagenomics analysis. This pair of siblings had a small mean 
number of PA-SNPs (?̅? = 23.5 if include both homo- and heterozygous PA-SNPs; ?̅? = 12.5 
homozygous; Table 2.1). When the second sibling line was sequenced, it was found to only share 
a single homozygous PA-SNP, that being in AHK4 (Figure 2.6F), which is consistent with this 
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being the causative mutation. Given the observed number of PA-SNPs, this fits with what our 
simulation mode would predict (Figure 2.5). To confirm that these two lines were true siblings, 
the network of shared identical SNPs, including those not predicted to affect protein coding, was 
examined; the large number of shared mutations confirms that these two lines are indeed sibling 




Figure 2.6. Sibling analysis used to identify hy5 in two sibling lines. A) Network of shared and unshared PA-SNPs in eah22-1 
and eah22-2, sibling lines containing a mutation in hy5. B,C) Representative images (B) of root elongation at 8 days after 
germination (DAG) for Col-0, ahp2,3, ahp1,2,3, hy5-SALK_096651C, eah22, and ahk2,4, grown on control and BA-treated 
media. Quantified root elongation data (C) from 3 to 8 DAG. Error bars are standard error. Letters indicate statistical 
significance following a Tukey post-hoc test. D) Comparison of HY5 binding sites with BA-treated type-B binding sites. Type-B 
binding sites for ARR10 (Zubo et al., 2017), and separately for ARR1, ARR10, and ARR12 (Xie et al., 2018) were compared with 
binding sites for HY5 (Lee et al., 2007b). E) Comparison of differentially expressed genes between BA and control-treated wild 
type plants and between BA and control-treated hy5. Differentially expressed genes are at least 0.5-fold different (on a log2 
scale) with BH-adjusted p-value < 0.02. F) Network diagram of PA SNPs of eah14. 
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We also analyzed the eah22 line, which had a comparatively small mean number (13) of 
homozygous PA-SNPs (Table 2.1). We sequenced a second eah line (eah22-2) derived from the 
same M1 pool that eah22-1 was identified from. There were only six genes that shared 
homozygous PA-SNPs in these two lines (Figure 2.6A). One of these, HY5, has in fact been 
suggested to affect cytokinin sensitivity (Cluis et al., 2004), but was not including in our original 
set of “known” genes due to its predominant role in light signaling. Consistent with the overlap 
of hy5 PA-SNPs, both eah22 siblings displayed characteristic hy5 phenotypes, such as an 
elongated hypocotyls and elongated, horizontal lateral roots (Oyama et al., 1997). To confirm 
that hy5 was the mutation responsible for cytokinin hyposensitivity in this line, we examined an 
independent hy5 mutant line. Similar to eah22, a hy5 T-DNA allele also conferred cytokinin 
hyposensitivity as measured using a root elongation assay (Figure 2.6B and 2.6C). We conclude 
that hy5 is the causative mutation in eah22, and further characterized the role of HY5 in 
cytokinin responsiveness. 
Mutations in HY5 alter the transcriptional response to cytokinin 
HY5 is a transcription factor involved in regulating the output of blue-light-responsive 
cryptochromes and their downstream processes, such as photomorphogenesis and anthocyanin 
production (Wang et al., 2001; Yang et al., 2001). In the dark, HY5 is degraded by COP1, an E3 
ubiquitin ligase (Ma et al., 2002; Bauer et al., 2004). When plant cells are exposed to light, 
COP1 production declines and HY5 accumulates. We hypothesized that HY5 may play a role in 
the transcriptional response to cytokinin. To test this, we first determined if the HY5 binding 
sites in the genome correlated to the binding sites for the type-B ARRs. We compared the ChIP-
chip (Lee et al., 2007b) peaks determined for HY5 with the peaks derived from a ChIP-seq 
analysis of several type-B ARRs (ARR1, ARR10, and ARR12) (Zubo et al., 2017; Xie et al., 
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2018) (Figure 2.6D). There was highly significant overlap between genes with adjacent type-B 
ARR and HY5 binding sites across the genome (p-values for the overlap of HY5 with ARR10 
(Zubo et al., 2017), ARR1, ARR10, and ARR12 (Xie et al., 2018)  by a hypergeometric test are 
6.81e-257, 2.4e-267, 5.6e-283, and 1.9e-252, respectively). For example, 45% of the genes 
identified as having adjacent HY5 binding sites also are targeted by ARR12. This suggests that 
these transcription factors share many common targets.  
We next examined the role of HY5 in modulating cytokinin-mediated changes in gene 
expression. Wild-type and hy5 (T-DNA allele) mutant roots were treated with a vehicle control 
or 0.1 µM BA and RNA transcript levels determined by RNA-Seq (Fig. 2.6E). A total of 347 
genes were upregulated after cytokinin treatment in wild type in these conditions (FDR of 0.02 
and log2 fold-change ≥ 0.5) (Table S2). Of those, 53% (185 genes) were not upregulated in the 
hy5 mutant (Figure 2.6E and Table S3). Likewise, 177 genes were down-regulated in response to 
cytokinin in wild-type roots, and 38% of these were not down-regulated in the hy5 mutant 
(Figure 2.6E and Table S3). Interestingly, there were a substantial number of genes up-regulated 
(49) and down-regulated (477) specifically in the hy5 mutant (Figure 2.6E). 
We also examined if changes in basal gene expression in the hy5 mutant affected 
cytokinin-regulated genes. There were 1,277 genes that showed increased and 954 decreased 
expression in the hy5 mutant as compared to wild-type roots (Table S4). These genes overlapped 
significantly with cytokinin DEGs in the wild-type roots (Figure S2), suggesting that disruption 
of HY5 alters the expression of a subset of cytokinin regulated genes in the absence of exogenous 
cytokinin. Together with the ChIP data, this data is consistent with HY5 playing an important 





Genetic screens are remarkably powerful tools to dissect biological processes, but the 
identification of causal genes can be a challenging task in Arabidopsis and other higher 
eukaryotic organisms. Genetic screens can result in dozens to hundreds of mutant lines 
depending on the design of the screen and the biological system in question. Current methods, 
such as mapping by sequencing, have greatly reduced the time required to map any single 
mutation, but these methods remain difficult to parallelize. The mutagenomics pipeline described 
here provides a means to identify causative mutations in a relatively rapid, parallel manner, 
facilitating the cloning of genes corresponding to many identified mutants. Mutagenomics has 
the capacity to accelerate the analysis of mutant screens, enabling exhaustive screening in 
Arabidopsis and other model organisms. 
We utilized the mutagenomics pipeline to preliminarily analyze 53 independent lines 
from an enhancer screen for cytokinin response mutants. This analysis identified the causative 
mutations in approximately half of these lines, demonstrating the utility of the approach. Further 
analysis of siblings can be applied to identify the causative mutations for the remaining lines. 
Alternatively, one could also use mapping by sequencing to analyze the remaining lines as a 
complement to mutagenomics.  
The foundational data for the mutagenomics pipeline is determining the genomic 
sequencing of the identified mutants as well as the un-mutagenized background genome for the 
screen. While, in theory, this could be done using M2 plants, in general it is highly advantageous 
to confirm the phenotypes of the isolated mutants after a re-screen of M3 seedlings, and this has 
the important advantage of identifying lines homozygous for the mutant phenotype. While 
recessive mutations will be necessarily homozygous in the M2 plants, dominant mutations will 
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be homozygous in the M2 generation only ~33% of the time, though if semi-dominant there 
would likely be a bias towards homozygous lines as they would have a stronger phenotype. To 
include dominant lines in mutagenomics, one could either identify a homozygous M2 sibling 
from the same pool (as evidence by lack of segregation of wild-type phenotypes in its progeny), 
or screen the progeny of various M3 plants for homozygosity. A target genome coverage of at 
least 15-20x provides adequate coverage for SNP calls. For Arabidopsis, a paired end 150 base 
pair sequencing protocol provided enough sequence depth to reach our target coverage and 
sequence 30 libraries per lane on a HiSeq4000 or HiSeq X10 platform. Attention should be paid 
to the expected number of clusters per lane for a given sequencing platform as this determines 
the number of individual fragments which will be contributing sequence information to the 
experiment. Paired end protocols will increase the sequencing depth for each library but will also 
increase the cost of the experiment. If a small number of libraries are to be sequenced and cost is 
a concern, a shorter read length protocol can be used or the experiment changed from paired end 
to single end. 
The first step in the mutagenomics pipeline is the identification of lines with mutations in 
known genes. In the case of a well-characterized pathway such as cytokinin signaling, there can 
be many potential known targets, but in more naïve screens, there may be few or no presumptive 
candidate genes, rendering this step unnecessary. A critical piece of information for this step is 
knowledge of the SNPs already present in the genetic background of the plants mutagenized for 
the screen. Novel genetic variation can accumulate as a stock is maintained for many 
generations, and if not filtered out of the variants observed in the mutant lines those background 
variants may obscure new mutations in important genes. In the cytokinin screen analyzed here, 
we included 23 genes related to cytokinin (including aux1, which is known to give cytokinin-
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insensitivity) and 18 previously identified in ethylene-insensitive screens that we anticipated 
might be identified in the eah screen (Table S1). As anticipated, mutations in several of these 
were indeed identified in the screen. However, identifying a mutation in a known gene does not 
guarantee that mutation is causative for the altered phenotype, so care must be taken to examine 
the specific mutation and to assess the plausibility of that mutation deleteriously altering the 
protein. Complementation tests can also be performed to confirm the causative nature of 
mutations in known genes. In any case, this step would help prioritize which lines to focus on in 
a screen for novel elements in a pathway as one would likely not pursue lines with mutations in 
known genes, whether complementation was tested or not. 
The second stage of mutagenomics is the comparison of independent mutations across all 
mutant lines to identify any genes mutated more times than expected by chance. Our simulation 
modeling indicates that the same gene can be found mutated in multiple lines randomly, which is 
not necessarily an intuitive prediction. In our case, in which we analyzed 53 mutant lines, there 
was a high likelihood (>90%) that a random gene will be mutated in up to four independent lines, 
and a reasonable probability in up to five lines (~25%). In our simulation, we mutate genes 
proportionally to their coding region length, which is a simplification as other factors such as 
chromatin state can affect mutability (Fahmy and Fahmy, 1971). Further, different genes are 
likely more or less sensitive to mutations affecting their function due to differences in the 
number of critical residues and some genes that give a weak phenotype even when harboring a 
null mutation would be under-represented in the identified mutant pools. These differences likely 
underlie the low number of times some known genes were identified in the eah screen. For 
example, AHP1 was surprisingly not found in our screen, even though it results in strong 
cytokinin-insensitivity when combined with ahp2,3 (Hutchison et al., 2006); this may reflect its 
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small size (154 amino acids) and/or low mutability. An ahk3 mutation was only found in a single 
line and ahk2 not at all, which may reflect their relative minor contributions to cytokinin 
signaling in the root, necessitating a strong/null allele to yield a phenotype that could be 
identified in the primary screen. 
The third stage of the mutagenomics pipeline relies on the ability to identify mutant lines 
of common descent (i.e. siblings). The ease with which this is accomplished depends to a large 
extent on the size of the M1 pools generated. At one extreme, an M1 pool size of one would 
greatly facilitate the identification of siblings, but would make the primary screen more tedious. 
At the other extreme, very large pool sizes would simplify the primary screen, but would make 
isolation of siblings more challenging. For example, the original pool size in our eah screen was 
slightly larger (140 per pool) than what is optimal for rapid sibling identification. Confirming 
that two mutant lines are siblings is clear-cut from genome sequencing data because siblings will 
share many common mutations, including both PA-SNPs and non-PA-SNPs, but independent 
lines should share no or extremely few common mutations. 
Highlighting the power of the mutagenomics process, we observed a line (eah14)  for 
which the causative gene was identified in all three stages of the mutagenomics process 
(detection of known gene mutations, over-enriched mutations, and mutations shared by siblings). 
The idea behind the sibling analysis is that in the mutagenesis process, the M1 plant 
acquires randomly allocated heterozygous mutations. Upon selfing, this will produce M2 
offspring segregating for all mutations, including the mutation of interest. The screen selects M2 
lines homozygous for the mutation of interest if recessive. Alternatively, homozygotes can be 
selected from M3 re-screens for dominant mutations. Thus, as one sequences additional sibling 
lines, they will be all be homozygous for the mutation of interest (as the phenotype selected for 
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this), with other random mutations segregating. Our simulation study suggests that sequencing 
just a few additional individuals rapidly reduces the candidate pool list down to a small, 
manageable number. For example, for mutant lines with fewer than 60 M1 homozygous SNPs 
(the average that we found in our screen) comparing only two additional sibling M2 plants (a 
total of 3 siblings) can result in an overlap list of close to five genes. This process can be carried 
out in the M3 generation as well, although the overlapping gene sets will be larger as 
heterozygous M2 SNPs have an opportunity to fix in the M3 generation. Additional siblings can 
be analyzed by whole genome resequencing, but if the number of candidate genes is small (<10), 
it may be more feasible to analyze remaining SNPs using a targeted PCR-based approach rather 
than generate a whole genome sequencing library. One complication in this analysis is that 
random mutations closely linked to the causative mutation will be difficult to separate if they are 
in cis to the causative mutation in the M1 plant, but this should represent a small minority of the 
overall PA-SNPs present. Subsequent tests (genetic complementation, isolation of T-DNA or 
CRISPR alleles) are required in any case to definitively identify the causative gene.  
While mutagenomics has the considerable advantages of being rapid, fairly easy to use, 
and capable of parallel analysis of many mutant lines, it may not be straightforward to identify 
the causative gene for every mutant line identified. For those mutant lines remaining after the 
mutagenomics pipeline, a more traditional bulked segregant mapping population could be 
employed. 
We used a screen for reduced cytokinin response in a root elongation assay to test the 
mutagenomic pipeline. The most frequently mutated gene to come out of this screen was AHK4, 
and this allelic series shed light on the residues essential for AHK4 function. We also further 
characterized the role of HY5 in the response to cytokinin. HY5 has been implicated as a link 
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between cytokinin and cryptochrome pathways (Vandenbussche et al., 2007), and hy5 mutants 
were found to be resistant to exogenous cytokinin in root and hypocotyl assays (Cluis et al., 
2004). We found that HY5 binds to an overlapping set of genomic targets with type-B ARRs, 
which mediate the primary transcriptional response to cytokinin (Zubo et al., 2017; Xie et al., 
2018). Consistent with this, HY5 is required for a subset of cytokinin-regulated gene expression 
changes.  
 There are 26 lines from our eah screen that do not harbor mutations in any of the known 
targets we screened for. These should provide rich fodder for further application of sibling 
analysis and perhaps bulk segregant mapping to identify new elements involved in the response 
to cytokinin. Future genetic screens would be better served by employing slightly smaller pool 
sizes to facilitate the third step in the mutagenomics pipeline.  
Conclusions 
Mutagenomics is a powerful approach to facilitate parallel processing of multiple mutants 
identified from genetic screens. This should empower all manner of screens in diverse genetic 
backgrounds in Arabidopsis. Further, mutagenomics is species agnostic, and can be applied to 
most model organisms.  
Material and Methods 
Plant material and growth conditions 
The ahp2,3 double mutant, the ahp1 control in Ws-0, the ahp1,2,3 mutant have been 
previously described (Hutchison et al., 2006). The hy5 allele is from the SALK T-DNA 
collection (SALK_096651C). The ahk2,4 line has been previously described as ahk2-7 cre1-12 
(Inoue et al., 2001; Yamada et al., 2001; Cheng et al., 2013). Seed were sterilized by incubating 
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in 95% (v/v) ethanol (1 min) followed by a 15 min incubation in 50% (v/v) bleach (Chlorox, 
8.25% sodium hypochlorite), 0.5% Tween 20 for 15 min. After sterilization, the seeds were 
washed 5 times with sterile water and then stratified for 3 days at 4° C. Root elongation assays 
were performed on half strength MS with 0.1 µM BA with 8 g/L Phytagel (Sigma Aldrich). 
Seedlings were germinated on retest media to match the initial screen conditions. Retest plates 
were grown vertically in constant light conditions at 21° C. 
EMS mutagenesis and screen for cytokinin hyposensitivity  
Ethyl methanesulfonate (EMS) mutagenesis was performed by incubating 1 g of dry 
ahp2,3 seeds in 100 mM pH 7.5 potassium phosphate buffer. EMS was added to a concentration 
of 0.4% v/v and the seeds were mixed on a rocking shaker for eight hours. The seeds were 
washed 20 times with water and sown directly on soil. The M1 plants were grown to maturity 
and the M2 seeds harvested in pools of approximately 140 M1 plants.  
For the primary assay, approximately 100 µL of M2 seed was sterilized and plated 
densely on media containing 0.1 µM BA. Pooled M2 seeds were plated in dense rows on BA 
plates and grown for five to eight days. Seedlings with roots longer than the surrounding 
seedlings were picked and transplanted to soil. Transplanted seedlings were grown to maturity, 
and M3 seed was harvested and stored at -20 C. Retesting of M3 seed was performed on BA 
media to verify cytokinin hyposensitivity. M3 seed was sterilized and plated on media containing 
0.1 µM BA plate at low density. A wild-type control was used on each plate. Three days after 
germination (DAG), the position of the primary root tips for each seedling was marked. Roots 
were scanned at 8 DAG and the distance from the mark to the primary root tip was measured 
using ImageJ (Abràmoff, 2004). The control and treatment root elongation values were 
compared using a single-tailed Welch’s t-test with α=0.975. 
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The lines were screened for ethylene responsiveness by plating on MS media containing 
10 µM ACC. After three days growth in the dark, the lines were scored for their triple response 
morphology (Guzman and Ecker, 1990). 
Library preparation for genome resequencing and RNA-seq 
For each mutant line of interest, one to four M3 plants were grown on selective media 
and inflorescences were collected from each plant. A modified CTAB extraction protocol (Doyle 
and Doyle, 1987) was performed to extract genomic DNA for genome resequencing. Frozen 
tissue was ground using a SPEX SamplePrep 2010 Geno/Grinder (Fisher Scientific). Ground 
tissue was mixed with 2x CTAB buffer. The homogenate was washed twice with chloroform. 
DNA was precipitated with 0.5X volume 5M NaCl and 2 volumes 100% ethanol and washed 
with 70% ethanol with 10 mM ammonium acetate. The DNA was then resuspended in 250 µL 
water with 10 µg ml-1 RNase A. The DNA was re-precipitated and washed with 70% ethanol, 
then resuspended in 50 µL water. 
Genomic libraries were then prepared using an Illumina TruSeq PCR-Free DNA library 
kit (Illumina # FC-121-3003) for the first two phases, and a Kapa HyperPrep DNA library kit for 
the third phase. Library concentrations were determined using a Kapa library quantification kit 
(Sigma/Roche #7960140001). Mutant re-sequencing was performed in three rounds, twice on a 
HiSeq 4000 (first and third phases) and once on a HiSeq X10 platform (second phase). 
SNP Detection 
Several processing steps are necessary after identifying SNPs in sequencing data. SNPs 
are filtered out of this set based on quality scores, presence in background mutants, and 
consistency with an EMS-derived mutation. After filtering, SNPs are analyzed using SnpEff 
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(Cingolani et al., 2012) to determine whether they are protein-altering mutations. The SnpEff 
output is then parsed to create final output tables and figures. Currently, these functions are 
performed by a collection of batch scripts calling R scripts and SnpEff. At publication, the 
collection of scripts will be packaged together in a GitHub repository such that advanced users 
could run analyses locally.  
Sequencing 
Genome resequencing was performed in 3 rounds. The first round of sequencing was 
performed with 33 libraries on a single lane of a HiSeq 4000 instrument (2x150 bp) by the High 
Throughput Sequencing Facility (HTSF) at UNC Chapel Hill. The second round was performed 
on a HiSeq X10 platform (2x150 bp) by BGI (Shenzhen, China). The third round was sequenced 
on a HiSeq 4000 (2x75 bp) by the HTSF at UNC Chapel Hill. The RNA-seq experiment was 
sequenced on a HiSeq 4000 in high output mode (2x75 bp) by the HTSF at UNC Chapel Hill. 
Mutagenomics Data Processing 
Sequenced libraries were aligned to the TAIR10 genome using Bowtie2 (Langmead and 
Salzberg, 2013). Variants were inferred using the Genome Analysis Tool Kit (GATK) (McKenna 
et al., 2010; DePristo et al., 2011; Van der Auwera et al., 2015). Detected variants were filtered 
based on their call qualities by GATK with the filterstring 
“QD<2.0||FS>60.0||MQ<40.0||MQRankSum<-12.5||ReadPosRankSum<-8.0”. Variants passing 
all GATK filters were further filtered by the read depth of the detected variant and by the 
predicted effect as determined by SnpEff (Cingolani et al., 2012). Only protein-altering 




AHK4 receiver domain structure 
The receiver domain structure was modeled using the HHpred and Modeller packages 
available at https://toolkit.tuebingen.mpg.de/ (Webb and Sali, 2016; Zimmermann et al., 2018). 
The response regulator domain (residues 946-1071) was submitted to the HHpred search and the 
top 100 matches were chosen to model the structure of the domain using Modeller. 
RNA-Seq Analysis 
The hy5 gene expression experiment was performed using RNA extracted from flash-
frozen tissue using an RNEasy kit (Qiagen, #74106). Samples of mRNA were isolated using 
Sera-Mag oligo dT beads (Thermo) in presence of RNase Out (Enzymatics) and heat-
fragmented. First-strand synthesis was performed with Enzscript (Enzymatics), and second-
strand synthesis with DNA PolI (Enzymatics) and RNase H (Enzymatics). End repair was 
performed with T4 DNA Polymerase (Enzymatics), Klenow polymerase (Enzymatics), and T4 
PNK (Enzymatics). A-tailing was performed with Klenow exo- (Enzymatics). Adapter ligation 
was performed with T4 DNA ligase (Enzymatics). The libraries were PCR-amplified using 
KAPA HiFi HotStart ReadyMix (Kapa Biosystems). All wash steps were performed with 
AMPure XP beads (Beckman Coulter). Read alignment was performed using star (Dobin et al., 
2013), and count data was normalized using Salmon (Patro et al., 2017). Differential gene 
expression analyzed using DESeq2 (Love et al., 2014) in R. The BH-adjusted p-value cutoff 
(Benjamini and Hochberg, 1995) used for determining significance was lowered to 0.02 to 





Independent Allele Simulations 
The algorithm for the independent allele simulations is as follows. First, a decision is 
made on how many genomes to simulate and how many mutations to allocate. In this study, the 
allocated mutations are assumed to represent homozygous recessive mutations. Mutations are 
randomly allocated across the genome using gene coding length as a weighting factor with the 
assumption that no gene will be mutated more than once. Once all simulated genomes have had 
mutations allocated to them, a network of mutated genes is generated and analyzed to determine 
whether any genes were independently mutated x or more times. This simulation process is 
repeated until a population of simulated screens is collected. Then, the population of screens can 
be assessed to determine the proportion n of all simulated screens in which a gene was 
independently mutated x times. This process can be repeated for different numbers of genomes 
and different PA-SNP densities. 
Sibling Allele Simulations 
Empirical crossover frequencies were taken from (Salomé et al., 2012), although the 
frequencies of no-crossovers and single-crossovers were combined into a single value for single-
crossovers. The algorithm for the simulation is as follows. For any given trial, a decision is made 
on how many siblings to simulate and how many protein-altering mutations to simulate. The 
chosen number of simulations are allocated to genes randomly in a heterozygous fashion. 
Mutations are allocated across the whole genome using individual gene coding region lengths as 
weighting factors. Two rounds of simulated meiosis are performed. In each, a number of 
crossovers to be performed is randomly sampled from the supplied empirical distribution. The 
positions of crossovers are randomly allocated, but assumed to always occur between genes. 
Sister chromatids are generated, and crossovers occur at the pre-determined positions between 
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randomly chosen non-sister chromatids. One of the four chromatids is randomly chosen to be 
either the pollen or ovule gamete. The recombination process is then repeated to generate the 
second gamete. The two simulated gametes are combined to form the M2 generation. The 
meiosis process described above is repeated to generate the M3 generation, and the whole 
process is repeated independently for each of the siblings in the trial. The number of genes in a 
homozygous state shared by all siblings in the trial is then recorded. This process can be repeated 
for different numbers of siblings and different PA-SNP densities. 
User requirements to perform mutagenomics  
Several programs are required for use of the Mutagenomics pipeline. The user should 
have access to a high-throughput computing platform to perform read alignment and variant 
calling. Once variant calling is completed, the user can move from a server to a personal 
computer. The scripts as written use Bowtie2 and the Genome Analysis Toolkit. 
The pipeline has been set up to be compatible with either a Mac/Linux or Windows 
operating system. Different versions of the scripts are provided depending on the operating 
system in use. The user is required to have R installed, either through the base RGui or the 
RStudio project, and to have the Rscript front-end command available from the command line 
(e.g. set in the PATH variable on Windows). The user should also have a bash shell installed. 
Macs have one by default, and Windows users can use Git Bash (available at 
https://gitforwindows.org/). The scripts rely on several GNU utilities (sed, find) that are native 
on Macs and available on Windows through projects like Cygwin (available at 
https://www.cygwin.com/) or GOW (Gnu On Windows, available at 
https://github.com/bmatzelle/gow/wiki). These scripts were developed on a Windows platform 
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using Git Bash and GOW. The user should also have a copy of the SnpEff program downloaded, 
available at snpeff.sourceforge.net. 
Code and Data Availability 
Statistical and data analyses were performed using R and Python. Code is available at 
https://github.com/KieberLab/Mutagenomics. The RNA-seq GEO accession number is 
GSE149641. The Mutagenomics sequencing data access number is PRJNA631403. 
Supplemental Data 
 For the supplemental data tables associated with this paper, please see (Hodgens, 2020). 
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CHAPTER 3: MUTAGENOMICS AND ITS APPLICATION TO ADDITIONAL 
MUTANT SCREENS 
 
Further evidence of the usefulness of the mutagenomics strategies  
This chapter is intended to be an accounting of several successful applications of 
mutagenomics beyond the scope of Chapter 2. First, I return to the eah screen and discuss results 
of that screen not already described in the previous chapter. This includes an additional sibling 
not documented in Chapter 2 and a close analysis of the remaining mutations in several mutants 
with low protein-altering SNP (PA-SNP) densities. 
Second, I will describe the use of mutagenomics by two colleagues and the results of 
those efforts. One of these is the ACC resistance (acre) screen performed by Asia Polko, a 
postdoctoral fellow in the Kieber lab, searching for mutations in Arabidopsis thaliana that confer 
resistance to the molecular precursor of ethylene, aminocyclopropane-1-carboxylic acid (ACC). 
One gene was observed to be mutated more often than by chance alone, and previous results 
strongly support that this is the causative gene. The second is the ghostbuster (gob) screen 
performed by Carly Sjogren, searching for suppressors of the POLTERGEIST-LIKE1 (PLL1) 
gene. The sequenced lines in the gob screen were chosen to make maximal use of sibling 
analysis, and many sibling groups were identified. Both of these screens leverage different 




Third, I will present a counterfactual exercise: if modern genome sequencing technology 
had been available to researchers in the 1970s and 1980s, how could mutagenomics have 
benefited mutant screens performed at the time? The example used is the Heidelberg screen, a 
classic genetic screen in Drosophila melanogaster which discovered many critical genes for 
embryonic development in flies. I show that if sequencing had been available, then several genes 
were identified that were mutated more frequently than would be expected by chance alone.  
Further analysis of the eah screen 
The previous chapter documented the enhancer of AHPs (eah) screen in Arabidopsis 
thaliana and the mutagenomics strategy developed during that screen. The results described 
therein were an abbreviated version of the full results of the eah screen. Several mutants with 
low SNP densities were documented but not discussed, one member of a sibling pair was 
omitted, and several experiments are needed to complete the analysis of the screen. It is my hope 
that future researchers can pick up these loose threads and follow them to new discoveries. In the 
interest of aiding those researchers, this chapter will complete the description of the eah screen. 
Sequencing for the eah screen was carried out in three phases. The objective of the first 
phase was the detection of mutations in known genes in 29 eah mutants gathered during the 
screen. This phase focused on independent alleles, although through a book-keeping error, two 
closely related lines, eah22 and eah24, were included. The observation of multiple mutations in 
the same genes between these two lines, and the realization that they were from the same pool 
and had similar root phenotypes, became the basis for sibling analysis. 
The second phase was meant to be a mix of completely independent eah mutants and 
mutants suspected to be siblings to already sequenced lines. Of the lines suspected to be 
 
46 
members of sibling sets, three lines turned out to be new sibling sets. This brought the total 
number of sibling sets to three:  
• eah22-1 and eah22-2, identified as having hy5 mutations 
• eah38-1 and eah38-2 
• eah14-1 and eah14-2, identified as having ahk4 mutations 
Due to bookkeeping errors, two sets of lines (eah16 and eah12) were sequenced twice. 
While unfortunate, some new information can be inferred from these lines. From a naïve 
examination of the network of shared alleles, these lines appear as siblings, not exact copies of 
each other. There are genes mutated in each duplicate sample that are uniquely mutated. 
However, this is not an unexpected result. The goal of sibling analysis is to determine which 
mutations are homozygous across all sequenced M3 samples, assuming a recessive phenotype of 
interest. A non-causative mutation can have varying prevalence across the samples. If many M3 
siblings are sequenced, then the experiment should have a comprehensive picture of the full set 
of mutations gained in the M1 plant. However, by only sampling a few M3 plants, there is the 
possibility that some genes are present in low levels or completely absent in the sampling 
population that contributed gDNA to the library. The set of genes which are homozygous in both 
of the two libraries will then be large, but not completely overlapping. However, it should still 
contain the potential causative genes of interest just as two true siblings would. 
If no new siblings can be found either by screening collected mutants or by re-screening 
the pools of M2 seed, then generating a new sampling population of M3 plants from the same 
seed stock could be used to define a set of genes that must contain the causative gene just as 
sibling analysis does. This set of candidates will be much larger than can be achieved with true 
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sibling analysis, but will also be smaller than the set of candidate mutations derived from just 
one library. 
The third phase of sequencing was an attempt purely to find siblings. However, many of 
the mutants sequenced in the third phase failed later phenotypic retests and have been removed 
from consideration. In the following sections, I will document the most promising candidates, 
summarize any relevant facts regarding their genome and detected SNPs, and give 
recommendations for follow-up. 
eah38-1 and eah38-2 are a sibling pair with a small number of shared PA-SNPs 
The eah38 lines (stock numbers #213 and #222, number 15-2 and 15-4) form a sibling 
group with 15 shared PA-SNPs. These lines are ACC sensitive and have no mutations in or near 
known cytokinin or ethylene signaling components. Eah38-1 has 83 total PA-SNPs and 47 
homozygous PA-SNPs. Eah38-2 has 99 total PA-SNPs and 20 homozygous PA-SNPs. The 
discrepancy in homozygous PA-SNPs (47 vs 20) is unusual compared to the other two sibling 
pairs (the eah22 set, with 10 and 16 homozygous PA-SNPs, and the eah14 set, with 14 and 11 
homozygous PA-SNPs). However, the number of heterozygous SNPs in each (83 and 99) is 
comparable and much larger than for eah22 and eah14, so the gap in homozygous PA-SNPs may 
be within the range of normal variation. The thresholds for calling SNP depth as heterozygous 
and homozygous are relaxed to account for a small degree of contamination (Hodgens, 2020), 
but if too much contamination is present then few confident SNP calls will be made. These two 
lines share 15 homozygous PA-SNPs which are list in Table 3.1. Identification of additional 
siblings or a backcross of one of the eah38 siblings to ahp2,3 may be useful, but 15 candidates is 
also a small enough list to manually screen. T-DNA lines for these genes have been ordered and 
testing of those lines is planned. 
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  Table 3.1: Homozygous PA-SNPs observed in the eah38 sibling set. 
Locus Info 
AT5G06400 PPR superfamily protein 
AT3G09700 Chaperone DnaJ-domain 
AT3G25700 Aspartyl protease 
AT3G19680 Hypothetical protein 
AT3G22800 LRR protein 
AT3G15130 TPR-like 
AT3G58020 Chaperone DnaJ-domain 
AT3G60370 FKBP20-2 immunophilin 
AT3G23790 AMP-dependent synthetase/ligase 
AT5G38520 CLD1 
AT5G07440 
Beta-subunit of glutamate 
dehydrogenase 
AT1G49430 Long chain acyl-CoA synthetase 
AT3G52860 Mediator subunit 
AT3G11460 DYW PPR protein 
AT2G02020 Major facilitator superfamily protein 
 
Several lines may be amenable to manual assessment of fixed mutations 
Three independent lines (eah49, eah36, and eah40) with a low number of PA-SNPs were 
identified that merit further investigation. These lines are not members of a sibling group and do 
not have mutated genes that rise to the level of enrichment in the experiment. Eah49 was isolated 
as mutant 66-4, stock #658, with 40 total PA-SNPs and 27 homozygous PA-SNPs. Eah 36 was 
isolated as mutant 110-7, stock #1157, with 24 total PA-SNPs and 12 homozygous PA-SNPs. 
Eah40 was isolated as mutant 17-3, stock #445, with 31 total PA-SNPs and 17 homozygous PA-
SNPs. We have screened the homozygous PA-SNPs for each line and narrowed the list down to 
a set of candidate mutations. The candidate mutations for eah49, eah36, and eah40 are shown in 





Table 3.2. Candidate causative PA-SNPs in eah49. 
Locus Info 
AT5G37720 
Interacting with DNA-Binding Domain 
of ZN-Finger Parp 1 (DIP2) 
AT3G08760 Stress Inducible Kinase 
AT3G43670 Copper Amine Oxidase Gamma 2 
AT1G77300 Early Flowering In Short Days (ESF) 





Peroxisome Unusual Positioning 
1/Autophagy 2 
AT4G39940 APS-Kinase 2 
AT4G27910 SET Domain Protein 16 





PA-domain containing subtilase family 
protein 
 
Table 3.3. Candidate causative PA-SNPs in eah36. 
Locus Info 
AT5G13520 Peptidase M1 family protein 
AT1G08270 Vacuolar protein sorting-associated protein 
AT3G04030 Homeodomain-like superfamily protein 
AT5G41610 Cation/H+ exchanger 18 
AT2G19560 Enhanced ethylene reponse 5 
AT3G17860 Jasmonate-zim-domain protein 3 
AT5G60280 L-type Lectin Receptor Kinase I.8 
AT5G08610 Pigment defective 340 
AT5G10900 Protein phosphatase 7-like 
 
   Table 3.4. Candidate causative PA-SNPs in eah40. 
Locus Info 
AT3G55410 
Leucine-rich repeate protein kinase family 
protein 
AT3G46340 2-oxoglutarate dehydrogenase, E1 component 
AT5G57010 
ATP-dependent caseinolytic protease/crotonase 
family protein 
AT3G05980 Calmodulin-binding family protein 
AT3G60510 Hypothetical protein 
AT4G23270 Cystein-rich RLK 19 




Several uncharacterized promising mutants require mapping or additional siblings 
A set of mutants were analyzed by mutagenomics but have not yet revealed a reasonable 
number of candidates genes to identify causative mutations. These lines (Table 3.5) are 
recommended for further study through a traditional mapping-by-sequencing approach 
(Velikkakam James et al., 2013) or by acquiring more siblings for each line. If one more sibling 
can be acquired for eah23, eah33, and possibly eah26, the set of shared mutations will likely fall 
below 20 genes and permit manual screening for candidate mutations. I recommend that a 
backcross be performed for eah9, eah44, and eah19, as two or more additional siblings may be 
required due to these lines’ SNP densities.  
Table 3.5. eah lines not characterized by mutagenomic analysis. 




eah9 89-1 932 120 71 
eah33 85-2 964 89 53 
eah26 110-3 1102 96 58 
eah44 44-10 646 117 68 
eah23 44-9 645 74 43 
eah19 83-10 1105 201 125 
 
eah5 may have a mutation in an unknown ethylene signaling component 
This line, isolated as mutant 35-6, stock #528, has one of the largest EMS loads of the 
sequenced lines. Sequencing indicates it has 163 total PA-SNPs and 99 homozygous PA-SNPs, 
so it is not amenable to manual screening of fixed alleles. The curious feature of this line is that it 
was weakly insensitive to ACC in a triple response assay but did not have a mutation in or near 
any ethylene signaling components. Backcrossing or the acquisition of additional sibling lines is 
recommended for this line. 
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The causative mutation for eah24 is likley be ahk3 
This mutant, number 65-8, stock #874, with 63 total PA-SNPs and 33 homozygous PA-
SNPS, possesses a stop mutation in AHK3 at Trp801*. This stop is in the middle of the receiver-
like domain in the protein, at residues 746-865 (Ueguchi et al., 2001a). This mutation is a 
plausible candidate for the causative mutation in eah24, but no complementation test has yet 
been performed. I have started growing plants to perform a complementation cross to eah24. 
The eah11 mutant may be an arr13 mutant 
This mutant, number 72-1, stock #809, has 97 total PA-SNPs and 65 homozygous PA-
SNPs. This mutant was initially scored as a moderate mutant, but on subsequent retests was 
identified as an unambiguously having a strong cytokinin-insensitive phenotype. It is sensitive to 
ACC in a triple response assay. This line harbors the following homozygous mutations: an intron 
variant in ARR13 (c.1665+65C>T), a mutation in the intergenic region downstream of AHP1 
(c.*3599G>A), and an intergenic mutation downstream of EDF3 (c.*4961C>T), an ethylene 
responsive transcription factor (Alonso et al., 2003). The mutation near ARR13, a type-B ARR 
(Mason et al., 2004; Schaller et al., 2008) is unlikely to be causative as it is intergenic, not 
located in a coding or splice site region, and the gene is weakly expressed in roots (Winter et al., 
2007; Klepikova et al., 2016). Mutations in edf3 are associated with enhanced root growth in 
seedlings grown on ACC media (Alonso et al., 2003), which is consistent with eah3’s phenotype 
on BA media, but eah11 is ACC sensitive by a triple response assay. The mutation in the region 
of AHP1 represents one of two times a mutation was observed near the gene (the other mutant 
being eah41). AHP1 was predicted to be mutated in this screen but no mutations within the 
AHP1 locus were observed. If this mutation is causative for eah11, it must be in a regulatory 
region critical for AHP1 expression. A complementation cross to ahp1 could resolve this issue. . 
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There are too many fixed PA-SNPs to manually screen so analysis of further siblings or a 
backcross to ahp2,3 could be pursued.  
The acre screen for ACC resistance demonstrates the enrichment of causative alleles in a 
screen 
The mutagenomics process was also applied to a screen performed by a postdoc in our 
lab, Asia Polko. Her screen was looking for mutants in pathways related the ethylene 
biosynthetic precursor molecule 1-aminocyclopropane-1-carboxylic acid (ACC). Previous 
research has established that a loss of function mutant in ein2, the primary receptor for ethylene 
disrupts biological responses to certain external stimuli. In etiolated wild type seedlings, ethylene 
treatment results in the triple response – apical hooking, inhibition of hypocotyl elongation, and 
hypocotyl swelling (Guzman and Ecker, 1990). Mutations in ethylene signaling components 
have only modest effects on plant growth and development and display an altered triple response 
in etiolated seedlings in response to exogenous ethylene. 
 Mutants disrupted for ACC synthesis are distinct from mutants disrupted in ethylene 
perception. In contrast to ethylene-insensitive mutants that have only subtle effects on growth 
and development, an octuple mutant in ACC synthase genes was embryo lethal (Tsuchisaka et 
al., 2009; Yoon and Kieber, 2013). This suggested that the ACC molecule itself may have a 
signaling role in plant development. Consistent with ACC acting as a signaling molecule 
independent of ethylene, inhibitors of ethylene biosynthesis (that is, affecting the ACC synthesis 
pathway) can affect root cell expansion phenotypes, but disruption of ethylene signaling cannot 
(Xu et al., 2008; Tsang et al., 2011; Yoon and Kieber, 2013). 
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 The acre screen designed to identify mutants insensitive to ACC. An EMS-mutagenized 
population in an ein2-5 background was screened for long roots in the presence of ACC. The 
number of EMS-consistent SNPs, all detected PA-SNPs, and homozygous PA-SNPs for the acre 
screen are summarized in Table 3.6. All the sequenced acre mutants are in theory from 
independent lines, but a naïve examination of the exact shared SNPs in the experiment suggests 
that two sibling sets exist: acre26-2/acre51-1 and acre61-3/acre56-1 (Figure 3.1A). The 
apparent acre26-2/acre51-1 sibling group has a shared SNP set with a Jaccard index of 0.99 
(SNP overlap shown in Figure 3.1B) and 13 shared homozygous PA-SNPs, and the apparent 
acre61-3/acre56-1 sibling group has a shared SNP set with a Jaccard index of 0.97 (SNP overlap 
shown in Figure 3.1C) and no shared homozygous PA-SNPs. If the acre lines comprising the 
apparent sibling sets are removed, there is further SNP enrichment visible. acre13-2 and acre65-
2 have their own distinct set of shared exact SNPs, and one SNP (Chromosome 5, position 
10969685, G->A) is shared between 8 independent lines. It is possible that the 5-10969685-G-A 
mutation is a causative mutation and an indication the acre screen is very saturated, but I believe 
it to be unlikely. Exact shared SNPs between independent lines have been observed, but rarely in 
more than three lines. Also, that position is in AT5G28930, a transposable element gene. The 5-
10969685-G-A mutation is likely a background mutation not captured in the libraries of pre-


















acre13-2 1049 304 116 shares SNPs with acre65-2 
acre25-3 885 262 125  
acre28-2 491 123 72  
acre32-2 815 221 123  
acre39-5 485 137 99  
acre59-5 579 159 75  
acre61-3 698 187 0 shares SNPs with acre56-1 
acre7-2 1002 304 238  
acre10-2 400 111 29  
acre14-1 762 225 173  
acre20-1 487 131 74  
acre21-1 635 154 79  
acre23-2 547 139 82  
acre26-2 824 234 27 shares SNPs with acre51-1 
acre30-1 617 167 117  
acre43-3 466 106 73  
acre49-2 600 167 104  
acre51-1 425 122 83 shares SNPs with acre26-2 
acre56-1 1030 298 146 shares SNPs with acre61-3 




Figure 3.1. Shared exact mutations in the acre screen mutants. A. Network diagram of EMS consistent SNPs (blue ellipses) 
shared by independent acre mutants (yellow rectangles). B,C. Overlapping and line-specific EMS mutations, both heterozygous 
and homozygous,  for acre26-2 and acre51-1 (B) and acre61-3 and acre56-1 (C). D. Subnetwork of acre lines with acre26-2, 
acre51-1, acre61-3, and acre56-1 removed. 
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The shared exact SNPs in acre26-2, acre51-1, acre61-3, acre56-1, acre13-2 and acre65-
2 are likely background mutations uncharacterized in the pre-mutagenesis libraries or real EMS 
mutations that appear shared by these independent libraries due to cross-contamination during 
tissue collection, library preparation, or seed harvest during the initial stages of the screen. If the 
pool of origin for one of each pair of mutants had been misrecorded, then the overlap in SNPs 
might represent legitimate common descent. I find this unlikely given that three different pairs of 
apparent siblings were observed. Without additional re-sequencing, there is no way to 
disentangle contaminant SNP calls from legitimate SNP calls. These lines will be removed from 
the current mutagenomic-oriented analysis. 
If no sibling pairs are present, then two avenues of mutagenomic inference remain: 
independent allele analysis and manual analysis of mutant lines with low SNP density. Once the 
6 suspect lines are removed, in the network of shared homozygous PA-SNPs, one gene 
(AT5G40780) was mutated four times and two genes (AT5G24740 and AT5G39000) were each 
mutated three times. In a network of 14 mutant lines, there is a near zero probability of a gene 
being independently mutated four times and a near 50% probability of a gene being mutated 
three times (Hodgens, 2020). The mutations in AT5G24740 and AT5G39000 may be false 
positives, but they may also be real signs of enrichment of a causative gene and should be 
examined. 
 AT5G40780 is LYSINE HISTIDINE TRANSPORTER1 (LHT1) and has previously been 
characterized as an ACC transporter (Shin et al., 2015). LHT1 is transport protein involved in 
lysine and histidine uptake in Arabidopsis and is expressed in the root epidermis (Chen and 
Bush, 1997; Hirner et al., 2006; Svennerstam et al., 2007). ACC is an amino acid derivative 
synthesized from methionine (Yang and Hoffman, 1984; Kende, 1993; Zarembinski and 
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Theologis, 1994) and a loss of function allele in lht1 was shown to have impaired uptake of 
radiolabeled ACC (Shin et al., 2015). The identification of four ACC resistant mutant lines with 
lht1 mutations is consistent with our knowledge of its role in ACC transport. The ACC 
insensitivity in these lines is likely the result of an inability to take up the exogenously supplied 
ACC. The mutations in acre25-3 and acre10-2 are missense mutations disrupting one of the 
predicted transmembrane domains (Chen and Bush, 1997), the acre20-1 mutation disrupts a 
splice donor site, and the acre43-3 mutation is a missense mutation in a predicted extracellular 
domain. The acre43-3 mutation, a leucine to phenylalanine change, is the most interesting, as its 
position in an extracellular domain suggests it may disrupt ligand binding or transport. 
Table 3.7: Mutations in LHT1 observed in the acre screen. 
Line Mutation Note1 
acre25-3 Pro387Ser Helical domain (residues 379-401) 
acre10-2 Ala271Val Helical domain (residues 269-289) 
acre20-1 581+1G>A Splice donor variant 
acre43-3 Leu148Phe Extracellular (residues137-157) 
 1Domain predictions by TMHMM (Sonnhammer et al., 1998; Krogh et al., 2001) 
Examination of the next most enriched genes demonstrates a subtle aspect of 
mutagenomics. It is not sufficient merely to look at the network of mutations in your experiment 
once. Rather, it must be an ongoing process where you consider the network in the light of new 
information. Two genes in the acre screen appear enriched, but on further examination the 
enrichment may be spurious. Three lines, acre20-1, acre23-2, and acre49-2, contained mutations 
in AT5G24740. This gene encodes SHRUBBY (SHBY), a vacuolar sorting protein (Gallagher and 
Koizumi, 2013). However, one of the lines with a shby mutation (acre20-1) also has an lht1 
mutation. The second case is similar. Three lines, acre32-2, acre25-3, and acre7-2, contained 
mutations in AT5G39000. This gene encodes MEDOS2 (MDS2), a CARANTHUS ROSEUS 
RECEPTOR-LIKE KINASE 1-LIKE (CrRLK1L) protein involved in adaptation to metal ion 
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stress (Gouget et al., 2006; Richter et al., 2018). However, like shby, one of the lines with a mds2 
mutation also harbors an lht1 mutation (acre25-3). 
It is possible, though highly unlikely, that two causative mutations for the acre phenotype 
could be observed in the same mutant line. This may have been the case for eah3, which has 
mutations in ein2 and ahk4, is cytokinin hyposensitive, and is weakly insensitive to ACC 
(Hodgens, 2020). However, two contributing mutations in the same mutant line is an unlikely 
scenario. For both the shby and mds2 mutations, the fact that one of the lines containing them 
also contains a plausible causative mutation in lht1 means that the mutations in shby and mds2 
are probably not causative for that line. The mutations in those genes may be false positives for 
those lines. That then reduces the number of informative mutations for each of those genes from 
three to two. For a 14 mutant screen, there is a 50% probability of at least one gene being 
mutated three times by chance alone, but a much higher probability of a gene being mutated 
twice. 
 Only one mutant line in the remaining 14 has a low enough density of homozygous PA-
SNPs to make manual discrimination of the mutations feasible, and that is acre10-2 with 29 
homozygous PA-SNPs. As noted earlier, acre10-2 has already been identified as a likely lht1 
mutant. The next lowest density line is acre28-2, with 72 homozygous PA-SNPs. Manual 
examination of the homozygous mutations is possible, but not feasible at this scale. This line 
would be an excellent candidate for sibling analysis, however. If two more sibling lines can be 
identified, the set of shared mutations would likely be reduced to 5-10 loci (Hodgens, 2020).  
The acre screen was designed for a traditional mapping-by-sequencing approach, and the 
mutants available reflect that goal. Single, strong mutants were selected from each pool to ensure 
that all analyzed mutants were independent. A screen that intends to apply mutagenomics 
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benefits from a comprehensive harvest of mutants, ideally collecting multiple strong, 
phenotypically similar mutants from each pool. Because of this, one half of the mutagenomics 
strategy is inapplicable to the acre screen. However, the acre screen still represents a successful 
application of the mutagenomics strategy. The mutations in lht1 were implicated as causative and 
independently implicated by a mapping-by-sequencing experiments. 
The ghostbuster screen demonstrates the utility of a sibling-focused sequencing strategy 
A second screen was performed and analyzed using a mutagenomics process by a 
colleague Carly Sjogren. This screen, titled the ghostbuster (gob) screen, was performed in a 
mutant with a loss of function mutation in POLTERGEIST (POL) and a hypomorphic allele of N-
MYRISTOYL TRANSFERASE 1 (NMT1). POLTERGEIST and POLTERGEIST-LIKE 1 (PLL1) 
are protein phosphatase type 2C proteins and regulate signaling through the clavata signaling 
pathway (Pogany et al., 1998; Yu et al., 2000; Song and Clark, 2005). Acylation by NMT1 is 
required for correct POL and PLL1 plasma membrane localization, a prerequisite for their 
regulation of clavata signaling (Song and Clark, 2005; Gagne and Clark, 2010). The 
hypomorphic allele of nmt1 partially impairs the remaining PLL1 protein, resulting in failure of 
carpel organ development in approximately 50% of flowers. Mutations in genes affecting PLL1 
function result in partial restoration of carpel organ development. All gob mutants sequenced for 
this analysis had 75% or more of flowers with wild type carpel development. This hypomorph 
approach is necessary because a pol pll1 double mutant is seedling lethal (Song and Clark, 
2005). 
The gob screen consists of 81 lines from 19 pools. The priority in choosing lines was to 
identify sibling groups. Sibling groups of two, three, and four siblings were identified. I intend to 
briefly summarize the results of the gob screen from the point of view of assessing whether this 
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application of mutagenomics was successful in identifying shortlists of plausible candidates in 
sibling sets, enriched alleles, and mutants with low PA-SNP densities. I will briefly discuss the 
sibling sets identified in the experiment and the size of the sets of mutations shared by all 
siblings, but I will not be parsing the list of mutations for plausible candidate genes. Several 
genes show potential enrichment in the gob screen and I describe their identity, but I do not 
evaluate their biological plausibility as causative mutations. And finally, I identify several lines 
with homozygous PA-SNP densities low enough to make manual assessment of the mutations 
feasible. 
The screen background libraries do not capture all variation in the mutated seed stock 
On first examination, it is clear that background mutations are present in the experiment 
that were not accounted for in the pre-mutagenesis background libraries. An additional 40 
mutations (Table 3.8) were detected that were present in five or more independent lines and may 
be background mutations rather than true EMS-derived variants. The largest sibling group in the 
gob screen is four, so any mutation present in more than four lines must be either a background 
SNP not identified by the background libraries or a coincidental exact SNP.  Pools 20 and 21 
contained a large portion of the background variants, accounting for 21 of the 40 SNPs. It is 
possible some of these SNPs are coincidences. If one non-background SNP was present in all 
four members of a sibling group (and thus one initial M1 plant) and in another singular line from 
another pool, then it would appear to be a background SNP when it is truly a novel EMS SNP. 
This might be the case for the 5.19173591.C.T mutation observed once in pool 14 and four times 
in pool 21, or for the 2.19465836.G mutation observed twice in pool 17 and three times in pool 
16. However, pool 21 contains many instances of a SNP being present in four pool 21 lines and 
one pool 20 line. A few SNPs could have been mutated by chance in both pool 21 and pool 20, 
 
61 
but for 21 SNPs to be shared is unlikely. There may have been a rare lineage of background pol 
stingy plants only represented in the M0 seeds which were mutagenized to form pools 20, 21, 
and 14. 
Table 3.8. EMS-consistent SNPs observed in the gob screen which are possible background 
mutations. 
Mutation Line Presence Mutation Line Presence 
1.13082075.C.T 27 (4), 4 2.19697585.G.A 16, 17, 20, 28, 9 
1.14855741.C.T 13, 24, 25 (4) 2.4923157.C.T 
1, 21 (2), 2 (3), 24 (3), 25 
(3), 26, 27, 28, 4 (2), 9 
1.15041793.C.T 1, 24, 27, 28 (2), 4 2.5213550.C.T 13, 2, 28, 21, 9 
1.15424317.C.T 9, 28, 4, 2, 21 3.10062955.G.A 20, 21 (4) 
1.15435612.C.T 12, 20 (2), 2, 24, 25, 26 3.11029273.C.T 20, 21 (4) 
1.15435619.C.T 2, 12, 20, 24, 26 3.14204677.C.T 1 (2), 26, 27 (2), 28, 9 
1.17479888.C.T 20, 21 (4) 3.14254451.G.A 
1, 12, 14, 18, 2 (2), 24, 25 
(2), 27 (2), 4, 6, 9, 20, 21 
1.17661315.C.T 20, 21 (4) 3.1705782.C.T 20, 21 (4) 
1.19077605.C.T 20, 21 (4) 3.21485063.C.T 12 (2), 13, 17, 25 
1.19452909.C.T 11, 25, 27, 9, 2 3.6055128.C.T 20, 21 (4) 
1.20275608.C.T 20, 21 (4) 3.6349104.C.T 20, 21 (4) 
1.20514812.C.T 20, 21 (4) 3.8901306.G.A 
1, 2, 26, 27 (2), 4 (2), 9, 
21(3) 
1.23395332.G.A 20, 21 (4) 3.9911373.C.T 20, 21 (4) 
1.28735948.C.T 20, 21 (4) 4.11477826.C.T 20, 21 (4) 
1.3699161.G.A 20, 21 (4) 4.18043997.C.T 20, 21 (4) 
1.9424452.G.A 20, 21 (4) 4.9044667.C.T 1, 12 (2), 20 (2), 2 
2.11532776.G.A 20, 21 (4) 5.19173591.C.T 14, 21 (4) 
2.15793293.G.A 20, 21 (4) 5.5283379.C.T 20, 21 (4) 
2.17946228.G.A 
17, 2, 21 (3), 25 (2), 26, 
27, 28, 4, 9 (2) 5.8088953.C.T 20, 21 (4) 
2.19465836.G.A 16 (3), 17 (2) 5.8201672.G.A 
1 (3), 13, 14, 17, 21, 24, 
25 (2), 26, 27, 28, 4, 9(6), 
2, 21 (3) 
 
The ghostbuster screen identified candidate causative mutations for several sibling sets 
The gob pool 2 mutants contain three apparent sibling groups: one group of gob2-23 and 
gob2-24 (SNP information summarized in Table 3.9), a group of gob2-38, gob2-14, and gob2-27 
 
62 
(Table 3.10), and a group of gob2-10 and gob2-48 (Table 3.11). There is also a set of nine exact 
shared SNPs between individuals in the three groups (Table 3.12) which may be background 
SNPs.  
Table 3.9. gob2-23 and gob2-24 form a sibling group. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob2-23 451 117 94 
gob2-24 492 136 97 
 
Table 3.10. gob2-38, gob2-27, and gob2-14 form a sibling group, with 11 
shared homozygous mutations between them. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob2-38 201 46 24 
gob2-14 229 50 29 
gob2-27 233 61 34 
 
Table 3.11. gob2-10 and gob2-48 are a spurious sibling group. The number of 
EMS-consistent SNPs between the two lines varies by 279 yet these lines only 




The sibling group consisting of gob2-23 and gob2-24 (Table 3.9) shares 84 homozygous 
PA-SNPs. Few inferences can be made from this overlap set. The acquisition of additional 
siblings to shrink the set of shared mutations is recommended. The triple sibling group of gob2-
14, gob2-27, and gob2-38 contains only two genes with homozygous PA-SNPs. These two genes 
are AT3G49900 and AT3G03580. AT3G49900 is described as a phototropic-responsive NPH3 
family protein but it does not have the NPH3 domain involved in blue light phototropism that 
other members of its family possess (Gingerich et al., 2005). AT3G03580 is MITOCHONDRIAL 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob2-10 732 186 103 
gob2-48 453 101 73 
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EDITING FACTOR 26 (MEF26), a gene involved in transcript editing for several mitochondrial 
genes (Arenas-M. et al., 2014). 
Some mutations identified in the pool 2 set of gob mutants have been classified as likely 
background contaminant SNPs. These SNPs are documented in Table 3.12. These SNPs are 
shared between at least two sets of the three apparent sibling groups in pool 2. 
Table 3.12. EMS-consistent mutations observed in the pool 2 set of gob mutants. The 
“Line Presence” column indicates which of the gob pool 2 mutants contains the given 
mutation. The mutation format is [Chromosome].[Mutation position].[Reference 
base].[Mutant base]. 
 
These SNPs were removed from consideration for further analysis of the pool 2 sibling 
sets. After removal of those SNPs, four SNPs remain shared between gob2-48 and gob2-10 and 
two of those are PA-SNPs at two loci: AT5G21326 and AT5G50920. AT5G50920 is CLP 
PROTEASE C HOMOLOGUE 1 (CLPC1), a chloroplast chaperone protein (Adam and Clarke, 
2002; Hengge and Bukau, 2003; Constan et al., 2004). A missense mutation at Gly534Glu was 
observed; this position overlaps a predicted UVR domain from residues 511-546 (Sigrist et al., 
2013). AT5G21326 is CBL-INTERACTING SERINE-THREONINE PROTEIN KINASE 26 
(CIPK26) (Drerup et al., 2013). A missense mutation at Thr221Met was observed; this position 
is inside the protein kinase domain (Sigrist et al., 2013). However, there is also a possibility that 
the remaining SNPs are either coincidental or additional background mutations. Gob2-48 has 
Mutation Line Presence 
5.21712990.G.A gob2-24, gob2-48, gob2-14, gob2-10, gob2-27 
5.5987533.G.A gob2-48, gob2-14, gob2-10, gob2-27, gob2-38 
1.926694.C.T gob2-24, gob2-14, gob2-10, gob2-38, gob2-23 
5.6702396.G.A gob2-48, gob2-10, gob2-38 
5.8228650.G.A gob2-14, gob2-10, gob2-38 
5.284841.G.A gob2-24, gob2-48, gob2-14, gob2-10, gob2-27, gob2-38, gob2-23 
1.22743467.G.A gob2-24, gob2-48, gob2-14, gob2-10, gob2-27, gob2-38, gob2-23 
5.6025779.G.A gob2-48, gob2-14, gob2-10, gob2-27, gob2-38 
1.15645910.G.A gob2-24, gob2-48, gob2-14, gob2-27 
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453 EMS SNPs and gob2-10 has 732 SNPs, almost twice as many. Siblings typically have 
different numbers of SNPs but the difference between their SNP densities is usually low, on the 
order of 50-100 SNPs. Also, only sharing 4 SNPs between siblings is highly unusual given the 
number of EMS-consistent SNPs the lines have; the gob2-23 and gob2-24 lines have about the 
same number of SNPs as gob2-48 yet share 577 EMS-consistent SNPs. It is thus likely that the 
gob2-48 and gob2-10 sibling set is a spurious one and neither the clpc1 nor the cipk26 mutations 
are causative. Whether the shared EMS-consistent SNPs between these lines are background 
mutations or coincidence cannot be determined from this data. 
The gob1-18 and gob1-15 sibling set (SNP data summarized in Table 3.13) have 51 
homozygous PA-SNPs in common. The identification of additional siblings is recommended. 
Table 3.13. gob1-18 and gob1-15 form a sibling group. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob1-18 361 88 69 
gob1-15 395 93 59 
 
The sibling set consisting of gob24-15 and gob24-12 (SNP data summarized in Table 
3.14) have 18 SNPs in common. A thorough accounting of the mutations observed in this sibling 
set is beyond the scope of this report, but the number of genes is well within the range of 
feasibility for manual screening for plausible candidates. 
Table 3.14. gob24-15 and gob24-12 form a sibling group. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob24-15 412 109 38 




The pool 16 group of gob mutants illustrates one of the worst-case scenarios for sibling 
analysis (SNP densities summarized in Table 3.15). On average, including additional siblings in 
a sibling set should result in a set of shared mutations that is a smaller subset of the original 
sibling set. However, it is possible that the new sibling identified contains the exact set of 
mutations already observed. This could result in a case where moving from, for example, 3 
siblings to 4 does not reduce the set of shared mutations. This was the case for the gob16 set. 
gob16-15 was the fourth mutant sequenced from pool 16 and it was suspected to be a sibling of 
gob16-14, gob16-20, and gob16-31, which already shared mutations in 18 genes. Gob16-15 
contained mutations in all 18 of those genes as well as a few mutations shared uniquely with two 
or three of the other mutant lines.  
Table 3.15. gob16-14, gob16-20, gob16-15, and gob16-31 form a sibling group, 
with 18 genes mutated in all four lines. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob16-14 504 134 100 
gob16-20 511 119 73 
gob16-15 661 187 81 
gob16-31 555 143 87 
 
A sibling set is formed by gob9-1, gob9-3, and gob9-9 (SNP data summarized in Table 
3.16) with 19 PA-SNPs shared by all three siblings. A thorough accounting of the PA-SNPs in 
this sibling set is beyond the scope of this report, but 19 genes is within the range of feasibility 






Table 3.16. gob9-1, gob9-3, and gob9-9 form a sibling group, with 19 genes 
mutated in all three lines. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob9-1 618 178 128 
gob9-3 788 210 111 
gob9-9 604 159 140 
 
A sibling set is formed by gob12-27, gob12-5, and gob12-30 (SNP data summarized in 
Table 3.17) with 7 homozygous PA-SNPs shared by all three siblings. A thorough accounting of 
the PA-SNPs in this sibling set is beyond the scope of this report, but 7 genes is within the range 
of feasibility for manual screening for plausible candidates. 
Table 3.17. gob12-27, gob12-5, and gob12-30 form a sibling group, with 7 





A sibling set is formed by gob21-63, gob21-47, and gob21-58 (SNP data summarized in 
Table 3.18) with 10 homozygous PA-SNPs shared by all three siblings. A thorough accounting 
of the PA-SNPs in this sibling set is beyond the scope of this report, but 10 genes is within the 
range of feasibility for manual screening for plausible candidates. 
Table 3.18. gob21-63, gob21-47, and gob21-58 form a sibling group, with 10 
genes mutated in all three lines. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob21-63 404 100 62 
gob21-47 382 100 78 
gob21-58 496 116 46 
 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob12-27 473 126 32 
gob12-5 524 138 79 
gob12-30 517 133 68 
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A sibling set is formed by gob27-1, gob27-6, and gob27-9 (SNP data summarized in 
Table 3.19), with 16 homozyous PA-SNPs shared by all three siblings. A thorough accounting of 
the PA-SNPs in this sibling set is beyond the scope of this report, but 16 genes is within the 
range of feasibility for manual screening for plausible candidates. 
Table 3.19. gob27-1, gob27-6, and gob27-9 form a sibling group, with 16 genes 




The sibling set formed by gob9-4 and gob-22II (SNP data summarized in Table 3.20) 
contains 31 PA-SNPs shared between the two lines. An additional sibling would be beneficial in 
shrinking the set of shared PA-SNPs in this sibling set. It is possible to manually screen 31 genes 
for plausible candidates but the number of knockout lines required to test all candidates may 
approach infeasibility, especially if candidates from other sibling sets are being assessed at the 
same time. 
Table 3.20. gob9-4 and gob9-22II form a sibling group, with 31 genes 
mutated in both lines. 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob9-4 553 122 91 
gob9-22II 467 117 74 
 
Two lines, gob17-42 and gob17-44, form a sibling group with 16 genes mutated in 
common, and a third line (gob17-18) may form a sibling group with gob17-44 with two genes 
mutated in common. No PA-SNPs are shared by gob17-18 and gob17-42. The SNP data for 
these three lines is summarized in Table 3.17. The putative sibling status of gob17-18 may be 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob27-1 515 111 45 
gob27-6 512 110 53 
gob27-9 480 101 54 
 
68 
spurious. While all three lines have similar numbers of EMS-consistent SNPs and total PA-
SNPs, gob17-18 has more than twice as many homozygous PA-SNPs as gob17-44 and gob17-42 
(Table 3.21). A thorough accounting of the PA-SNPs in this sibling set is beyond the scope of 
this report, but 16 genes is within the range of feasibility for manual screening for plausible 
candidates. 
Table 3.21. Pool 16 mutants forming potential sibling group(s). 
Mutant Line All EMS SNPs All PA-SNPs Homozygous 
PA-SNPs 
gob17-44 662 175 68 
gob17-42 726 191 55 
gob17-18 766 202 135 
 
The remaining prong of mutagenomics is the examination of low-SNP-density mutants 
with no siblings or enriched mutations. The SNP density data for the remaining mutant lines is 
summarized in Table 3.22. Several lines stand out as good candidates for manual screening: 
gob12-1 (19 homozygous PA-SNPs), gob20-15 (16), gob20-68I (19), gob21-4 (40), gob21-55 









Table 3.22. Remaining mutants in the gob screen not part of a sibling group. 












gob1-7 462 115 60 gob25-22 679 200 101 
gob1-9 916 240 64 gob25-3 529 126 54 
gob11-5 600 169 121 gob25-4 693 186 95 
gob11-9 309 75 48 gob25-7 501 126 72 
gob12-1 176 40 19 gob25-9 870 248 103 
gob12-29 565 155 112 gob26-10 957 266 82 
gob13-35 581 152 96 gob26-11 170 28 10 
gob14-18 588 160 80 gob26-14 142 18 12 
gob16-27 307 69 53 gob26-15 607 153 52 
gob16-46 469 119 57 gob26-16 389 103 49 
gob18-14 422 100 51 gob27-10 441 90 43 
gob2-10 732 186 103 gob27-4 498 108 72 
gob2-48 453 101 73 gob28-1 419 101 42 
gob20-68II 376 77 50 gob28-4 757 223 11 
gob20-15 429 94 16 gob28-5 346 81 44 
gob20-68I 441 93 19 gob28-6 553 115 63 
gob21-4 297 73 40 gob28-7 352 88 83 
gob21-3 845 235 134 gob4-1 606 157 104 
gob21-55 337 90 29 gob4-13 388 105 59 
gob21-6 367 84 31 gob4-18 692 175 54 
gob21-60 428 92 46 gob4-38 712 168 101 
gob21-7 531 128 80 gob6-17 371 88 49 
gob24-11 498 120 43 gob9-21 654 201 111 
gob24-24 451 100 55 gob9-21 577 171 97 
gob25-17 774 197 65 gob9-23 512 155 109 
 
No genes harbored more mutations than expected by chance in the full 81-library 
network. If sibling groups are removed, reducing the network only to 50 libraries with no 
remaining sibling information, several genes have enrichment which is possible but not 
guaranteed with a network of the given size. Five mutations were observed in COP1-
INTERACTIVE PROTEIN1 (CIP1, AT5G41790), a protein involved in mediating regulation of 
COP1 protein (Matsui and Deng, 1995). Four mutations were observed in each of OCTOPUS-
LIKE1 (OPL1, AT5G01170) and ESSENTIAL FOR POTEXVIRUS ACCUMULATION1 (EXA1, 
AT5G42950). OPL1 is a homolog of a regulator of protophloem development expressed in 
mature xylem tissue (Nagawa et al., 2006; Ruiz Sola et al., 2017). EXA1 is a protein involved in 
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the response to infection by a plantago asiatica mosaic virus (PIAMV) (Hashimoto et al., 2016). 
These three genes may not be causative in the gob screen but are still good candidates for further 
study. 
Mutagenomics as applied to the gob screen was able to produce experimentally tractable 
lists of candidate mutations for 9 pools and lists which could be reduced to tractable status in two 
other pools. Additionally, 9 independent mutants were identified with tractable sets of 
homozygous mutations and three genes were tentatively identified. These results make the gob 
screen the most successful application of mutagenomics to date and an exemplary model for 
future screens. 
The Heidelberg screen identified several enriched alleles 
The eah, acre, and gob screens all demonstrate the efficacy of the mutagenomics 
strategies. However, the acre and gob screens are incomplete, and while some of the mutants in 
the eah screen have been characterized, there remain many un- or partially-characterized lines. 
Further demonstration of the viability of the mutagenomic strategy may help convince any who 
remain skeptical. To that end, I examined a classic genetic screen the results of which are long 
verified. 
Specifically, I returned to the Heidelberg Screen in Drosophila melanogaster (Nüsslein-
volhard and Wieschaus, 1980). In that screen, 600 mutants were identified describing 120 loci, 
with 100 loci having more than one allele represented. The D. melanogaster genome contains 
13,957 protein coding genes and a 142 Mbp genome (Gelbart et al., 1996), fairly comparable to 
the Arabidopsis genome. The dosage used to mutagenize the flies mutated approximately 14 
genes per sperm (Wieschaus and Nüsslein-Volhard, 2016). A series of 10,000 simulated 
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mutagenesis experiments was performed using the D. melanogaster genome statistics and the 
above mutation rate to estimate the null distribution of shared alleles in the Heidelberg Screen 
(Table 3.23) using the same simulation methods described in the previous chapter (Hodgens, 
2020). If high-throughput sequencing had been available at the time, then within the 
mutagenomics framework, wingless, patch, paired, Krüppel, and knirps could have been quickly 
identified as plausible candidates for causative mutations without needing to map the genes 
(Table 3.24). 
Table 3.23. Simulation-derived probabilities of multiple alleles in the same gene 














Table 3.24. Alleles identified in the Heidelberg screen indicated as enriched by 
mutagenomics. 
Class Locus Number of alleles 
Segment-polarity wingless 6* 
 gooseberry 1 
 hedgehog 2 
 patch 8* 
 paired 3* 
 even-skipped 2 
Pair-rule odd-skipped 2 
 barrel 2 
 runt 1 
 engrailed 6 
 Kruppel 6* 
 knirps 5* 
Gap hunchback 1 







CHAPTER 4: INDCAPS: A TOOL FOR DESIGNING SCREENING PRIMERS FOR 
CRISPR/CAS9 MUTAGENESIS EVENTS  
 
Introduction 
It is often necessary to genotype biological samples to select individuals from a large 
population with a desired genetic variant. Genetic variants generated by mutagenesis or natural 
variation can take the form of single nucleotide polymorphisms (SNPs) or insertions/deletions 
(indels). Sufficiently large indels can be distinguished using PCR followed by agarose or 
polyacrylamide gel electrophoresis (PAGE), but differences of one or two base pairs can be 
difficult to distinguish reliably even with PAGE, and SNP alleles are refractory to size-based 
genotyping. Diagnostic tools for genotyping samples with SNPs or small indels include PCR-
based cleaved amplified polymorphic sequences (CAPS) or derived CAPS markers (dCAPS) 
(Neff et al., 1998). A typical CAPS assay consists of a short amplicon centered on a restriction 
site present in only one genotype. The CAPS assay identifies the genotype of the individual 
based on whether or not the PCR product is cleaved by the differential restriction enzyme (Fig 
1A). A dCAPS assay can be used if there are no restriction sites differentially present in the wild-
type and mutant genomic sequences. The dCAPS assay introduces or disrupts a restriction 
enzyme motif near the mutation by amplifying the target sequences using an oligonucleotide 
primer that includes one or more mismatches relative to the template (Fig 1B). The mismatches 
are chosen so that following amplification, a restriction site is introduced into either the wild-
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type or the mutant amplified fragment, which can then be distinguished by restriction enzyme 
digestion followed by agarose gel electrophoresis.  
 
Figure 4.1. CAPS/dCAPS markers can distinguish alleles, but output of dCAPS Finder 2.0 can be flawed. (A) Diagram of 
CAPS technique. An amplicon centered on a restriction site (blue bar) disrupted by a SNP or indel (red bar) is differentially 
cleaved by a restriction enzyme (RE) in the wild- type vs mutant. (B) Diagram of the dCAPS technique. A restriction site can be 
introduced into either the wild-type or mutant target sequences using mismatched oligonucleotide primers to discriminate two 
sequences. The mutation (green bar) disrupts the introduced restriction site such that it is not cleaved by the restriction enzyme 
(RE). Gel electrophoresis can be used to identify the size difference between the wild-type and mutant fragments in both the 
CAPS and dCAPS methods. (C-F) A sequence with a two base pair deletion at a CRISPR cut site, chosen using CRISPR-Plant 
(Xie et al., 2014), was supplied to dCAPS Finder 2.0 with a mismatch allowance of 1 base pair. A minority of proposed assays 
are viable (C), but others possess too many mismatches for successful amplification by PCR or do not introduce diagnostic 
restriction sites (D-F). 
As CRISPR/Cas9-generated mutant alleles become more prevalent, there is a growing 
need for a facile method for screening and genotyping indel alleles (Housden and Perrimon, 
2016; Farboud, 2017; Karkute et al., 2017; Tandon et al., 2017). Assays based on dCAPS 
markers are ideal for this as they are simple, robust, inexpensive, and relatively high throughput. 
However, designing productive primers for allele-specific dCAPS assays can be cumbersome.  
Here, we present the development of a new web-based tool to design dCAPS primers for 
indels that should be of general utility for analysis of CRISPR/Cas9-generated mutant alleles in 
any species. We demonstrate the utility of this tool using CRISPR/Cas9 targeting of the AHK3 
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locus in Arabidopsis thaliana. AHK2, AHK3, and AHK4 are the three receptors present in 
Arabidopsis that are involved in the perception of cytokinin, a plant hormone regulating a 
diverse set of biological functions in plants (Kieber and Schaller, 2014). Previous studies have 
identified null alleles of ahk2 and ahk4, but the previously identified ahk3-3 allele is 
hypomorphic rather than a null allele, as residual full-length AHK3 transcript was found to be 
present in ahk3-3 seedlings (Cheng et al., 2013). Primers generated by the indCAPS tool were 
successfully used to identify editing events at the AHK3 locus, and viable triple null mutant lines 
for the cytokinin histidine kinase receptors were identified. The indCAPS tool has the potential 
to be an important resource for investigators seeking to find new CRISPR alleles or design 
genotyping primers for known alleles.  
Materials and methods  
Software  
The indCAPS package was written in Python (version 3.5.2) and is implemented as a 
webapplication using the flask framework (0.12), the bleach package (1.5.0) for input scrubbing, 
and the gunicorn WSGI HTTP server (19.7.1). It is provided through an OpenShift application 
platform available from UNC-Chapel Hill. The website is available at http://indcaps.kieber. 







Plant growth and transformation  
Plants were grown at 21˚C in long days (16 h light). The ahk2-7 cre1-12 double mutant 
was transformed with pCH59, a pCUT series binary expression vector containing AHK3-
targeting gRNA sequences and expressing plant codon optimized Cas9 (Peterson et al., 2016), by 
the floral dip method (Clough and Bent, 1998). Putative transformants were selected on 
Murashige and Skoog media containing 50 μg/ml hygromycin and then transferred to soil and 
allowed to set seed. T2 seeds were plated on Murashige and Skoog plant growth media (2400 
mg/L MS salts, 250 mg/L MES buffer) (Murashige and Skoog, 1962), and then seedlings were 
transplanted to soil and genotyped for editing at the AHK3 locus. 
Detection of ahk3 mutations using dCAPS 
Oligonucleotide primers were designed to detect editing at the AHK3 locus using the 
indCAPS tool. Amplification of the AHK3 locus was performed with primers AHK3.dC.F and 
AHK3.dC.rc (data in S1 Text) followed by digestion of the amplicon with Bsa BI. Digests were 
analyzed using gel electrophoresis with a 3% agarose gel. Lines lacking any wild-type digestion 
pattern were selected for analysis. Sanger sequencing was used to characterize editing events as 
single base-pair indels and to confirm homozygosity. 
Results and discussion  
dCAPS Finder 2.0 has poor compatibility with indel alleles  
While a web tool for the design ofdCAPS primers has been described (Neff et al., 2002), 
it was designed primarily to detect SNP alleles. Primers generated with the tool for small indels 
often will not actually amplify either the wild-type or mutant sequences by PCR, or in some 
cases will not actually distinguish between the wild-type and mutant sequences. For example, an 
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analysis of potential dCAPS primers generated by the existing dCAPS program 
(http://helix.wustl.edu/dcaps/dcaps.html) for indels in several genes in A. thaliana demonstrated 
that as few as 15% of the suggested primers are capable of distinguishing the provided alleles 
(AHK3, 50% capable; CENH3, 14%; AGO1, 17%; MED20, 13%; RB1, 15%, see Table 2.1 for 
further details). Primers from dCAPS Finder 2.0 were examined by constructing the amplicons 
which the primer would generate in both the wild-type and an edited sequence and examining the 
amplicons for utility in a CAPS or dCAPS assay. Many of the primer pairs are non-functional 
and either do not generate a diagnostic restriction site or likely would not amplify the target 
DNA due to alignment gaps or extensive 3’ mismatches between the primer and one of the 
template sequences (Fig 4.1C–4.1F). There are workaround methods for dCAPS Finder 2.0 in 
which the user supplies two sequences in which the terminal base is the indel, rather than placing 
the indel in the middle of the provided sequences. This approach will ignore any potential assays 
in which a restriction motif may overlap the indel site, as the program has no information about 
bases on the other side of the indel. The reason dCAPS Finder 2.0 falters on indel alleles is not 









Table 4.1. Number of productive primers generated for tested loci. Simulated amplicons 
were made using generated primers. Non-productive primers did not amplify sequences capable 
of being distinguished with a restriction digest. Problematic primers amplify sequences capable 
of being distinguished, but the reaction would likely not amplify DNA due to primer defects such 
as 3’ mismatches or gaps in alignment to provided sequence. Productive primers are expected to 
successfully amplify DNA capable of being distinguished by a restriction digestion. 







AHK3 AT1G27320 GGTTGAGATCAAGATAGACA 8 3 5 
CENH3 AT1G01370 TCACAACCTCGGAATCAAAC 3 3 22 
AGO1 AT1G48410 GAGCCTTCACCTCCTTCAGA 2 5 29 
MED20 AT2G28230 GGCTGCTTACTGTTGATCCT 0 3 20 
RB1 AT3G12280 CCCATTTGGTTCAATGGGCG 5 1 35 
 
A web-based tool for design of primers to detect indels: indCAPS  
A new software package, indCAPS, was developed to facilitate the design of dCAPS 
primers for indels. This software has also been adapted for the design of CAPS and dCAPS 
oligonucleotide primers used in PCR amplification of target sequences in order to screen for 
editing events following CRISPR/Cas9-mediated mutagenesis (Cong et al., 2013). The tool is 
available at http://indcaps.kieber.cloudapps.unc.edu.  
The interface presents two dialog boxes to the user. The first box is for the generation of 
dCAPS primers for known alleles. The second box is for the generation of dCAPS primers for 
detecting unknown alleles. The first box requires the user to submit two sequences. No 
assumptions are made about either sequence being a wild-type or mutant allele, so order does not 
matter. Ideally, each sequence is centered on the mutation of interest. The two sequences do not 
need to be the same length, but should have homology arms of at least 20 bases flanking the 
mutation of interest. The user is also asked to submit a maximum number of mismatches in the 
primer. The default value is 1 mismatch. Increasing the maximum mismatch value should result 
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in more enzymes being reported, but as with any dCAPS assay, this may result in primers which 
are less likely to successfully amplify DNA. 
Several advanced options are also available. Amplicon length can be specified. This 
parameter dictates how far downstream the tool examines the sequence when looking for exact 
matches for each restriction site. A restriction enzyme is rejected if there is a cleavage site in the 
shared downstream region, which would complicate the analysis of the diagnostic cleavage at the 
site of interest. Depending on the size of the submitted sequence, the amplicon length may be 
longer than the sequence available to the program. In this case, the entire submitted sequence 
downstream of the primer is considered. If the user intends to use a paired primer lying outside 
the sequence supplied to the program, the user should check that either no exact restriction 
digests are present in the region not shown to the program or any exact restriction sites will still 
permit discrimination between diagnostic bands when analyzed with gel electrophoresis. Primers 
can be chosen based on a strict primer length or by a target melting temperature. A target size 
may be desired if the user wishes to ensure that a sufficiently large fragment will be cleaved. 
This may be useful in GC rich areas where a primer designed to match a target melting 
temperature would be short, resulting in small shifts in band sizes after cleavage and 
electrophoresis. Melting temperature calculations are performed using the Nearest Neighbor 
method (Breslauer et al., 1986) using thermodynamic parameters published by Sugimoto et al. 
(Sugimoto et al., 1996), as implemented in the Oligo Calc tool (Kibbe, 2007). It is necessary to 
assume certain information about the primer concentration and sodium ion concentration in the 
PCR reaction to calculate the melting temperature. Default values have been provided, but those 
parameters can be modified as necessary by the user through the web interface. Also, primers 
which contain terminal 3’ mis-matches are rejected by default. Some researchers have reported 
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that certain terminal 3’ mis-matches are compatible with PCR (Newton et al., 1989; Kwok et al., 
1990; Simsek and Adnan, 2000; Inoue et al., 2001), but due to inconsistencies in the literature, 
the default assumption for this tool is that 3’ mismatches will not amplify. If the user wishes to 
allow certain 3’ mismatches, the option is available. If enabled, 3’ G/T mismatches are ignored. 
The second box presented by the tool to the user permits screening for mutagenesis 
events in a CRISPR-mediated mutagenesis experiment. The box requires the user to submit the 
wild-type genomic sequence the user intends to target. The sequence should contain at least 
twenty bases on each side of the cleavage site. The user should also include the CRISPR target 
site oriented 5’ to 3’, not including the PAM. The CRISPR target sequence is not required to be 
in the same orientation as the wild-type sequence. The tool assumes that the last base of the 
provided sequence immediately precedes the PAM if aligned to the wild-type sequence and that 
cleavage occurs at the -3 position. The mismatch max parameter behaves as it does in the first 
box. The final major parameter is the acceptable loss threshold, which is the percent of editing 
events the user is willing to miss with their screening. Lower values mean the user wants to 
detect more editing events. Higher values mean the user is willing to accept missing certain 
editing events. Missed editing events, in this context, are most likely to occur if an insertion 
event occurs relative to an enzyme with degenerate bases in its recognition motif. The advanced 
options are the same as for those in the first box. 
An additional application is facilitated by the first box, the known-alleles tool. CRISPR-
mediated mutagenesis events create random mutations at the target locus. It may be desired in 
some cases to generate an isogenic mutation in a novel biological context, such as a different 
ecotype or genetic background. This is especially useful in cases where multiple mutant loci 
must be maintained and introducing an isogenic mutation would prove easier than screening 
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multiple segregating loci as a result of a cross. The output of the known-alleles tool indicates 
which of the two supplied sequences is cleaved by the restriction digest. If the user supplies the 
wild-type sequence and the specific mutant sequence they wish to find and choose an assay 
where the mutant sequence is cleaved, then a CAPS/dCAPS assay can be used to screen a pool of 
CRISPR-generated mutants for a specific mutation. This could be feasibly accomplished by a 
two-step process, where primers generated by the unknown allele indCAPS application are used 
to screen for lines showing any evidence of CRISPR-mediated editing events, and then a second 
primer set is used to screen for a specific mutation within that population.  
After analysis is complete, the user may be presented with several candidate primers. The 
user is required to choose their own downstream primer. Currently, the primers are evaluated 
only by their length or melting temperature, depending on the user’s specification.. The user can 
choose any of the reported primers, but may prefer certain assays over others due to cost or 
availability of the enzyme, compatibility of the enzyme with their PCR conditions, or personal 
preference in enzyme choice. 
Technical details of the indCAPS package  
A general outline of the algorithm that was developed is illustrated in Fig 4.2. The user-
supplied sequences (based on the mutagenesis target) are compared by defining shared and 
unshared regions in each sequence. In the case of a SNP allele, each sequence will have an 
unshared region of one base. For indel alleles, the sequence with the deletion relative to the other 
will have an unshared region of 0 bases and the sequence with the relative insertion will have an 




Figure 4.2. Algorithm for generation of oligonucleotide primers useful for CAPS and dCAPS assays. Two user- supplied 
sequences are analyzed, with one end near the predicted mutation site. Shared and unshared regions are identified in each 
sequence. A sub-sequence near the last shared base from each direction is isolated and compared to a library of restriction 
enzyme recognition motifs (https://www.neb.com/tools-and-resources/selection-charts/alphabetized- list-of-recognition-
specificities). If a diagnostic site is detected, determined by an exact or close motif match in only one sequence, a primer is 
generated. The primer disrupts any exact matches present in the shared regions and is checked to ensure the mismatch number is 
less than the specified maximum. 
Two core assumptions are made when designing diagnostic assays: 1) designed primers 
must be wholly contained in the shared region; and 2) putative restriction sites must have at least 
one base pair of overlap with both the shared and unshared regions. A library of restriction 
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enzyme recognition sites (https://www.neb.com/tools-and-resources/selection-
charts/alphabetized-list-of-recognition-specificities) (excluding nicking or double-cutting 
enzymes) is compared to both shared regions and to a subsequence near the last shared base. 
Sequences are compared using a modified Hamming distance metric, where the number of non-
similar bases is counted, allowing for degeneracy. For example, the sequences GCAT and GGTT 
have a distance of 2, and the sequences GCAT and GYTT have a distance of 1. Each recognition 
site is iterated across the sub-sequence and the distance at each position is calculated. If the 
distance for a comparison is below the user-specified mismatch threshold, that position is stored 
as a potential assay. An enzyme is rejected if it cuts in the downstream shared region, and exact 
matches in the primer are disrupted with mismatches during the primer design stage. Each set of 
sequences is analyzed twice, once as supplied, and again using the reverse complement of each 
sequence. An enzyme that is rejected because it cuts in the shared, downstream region of both 
sequences from one direction may be suitable if the primer is aligned to the reverse complement 
of the two sequences. For efficiency purposes, primers are designed only if a potential 
CAPS/dCAPS assay is detected in comparisons of the input sequences; the number of 
comparisons made is reduced if primers are designed for specific assays rather than designing all 
possible primers and assessing them for compatibility with CAPS/dCAPS assays. Primers are 
designed with their 3’ end at the last shared base of the two sequences. The primer length is then 
extended in the 5’ direction to generate candidate output primers. Each candidate primer is 
assessed by its length or melting temperature, according to the user’s choice, and the primer best 
matching the chosen criterion is reported.  
For the purpose of CRISPR/Cas9 screening, a profile of possible editing events is used to 
simulate editing events in the wild-type sequence. Currently, the default editing events are single 
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base pair insertion and deletion events. Future versions of the software will allow the user to 
supply a custom profile of events. The user is required to provide the specific target sequence 
used in CRISPR/Cas9 mutagenesis and the cut site is assumed to be at the -3 position of the 
provided 20-bp target (Cong et al., 2013). All possible sequence variants are created and 
compared to the wild-type sequence to identify the last shared base. The last shared base is taken 
to be the last base in the wild-type sequence shared with all sequence variants. A simplifying 
assumption is made when designing primers for unknown alleles: cleavage will occur in the 
wild-type sequence and will be disrupted in mutant sequences. 
Use of indCAPS to find mutants in cytokinin signaling 
Cytokinins, a class of adenine-derived signaling molecules are involved in regulating a 
diverse set of biological processes. Cytokinins are perceived by Arabidopsis Histidine Kinase 
(AHK) proteins (Inoue et al., 2001; Yamada et al., 2001) in the endoplasmic reticulum (Caesar et 
al., 2011; Wulfetange et al., 2011), which undergo autophosphorylation on a His residue. This 
phosphate is ultimately transferred to either type-A or type-B Response Regulator proteins 
(ARRs) via the Histidine Phosphotransfer (AHP) proteins (Hutchison et al., 2006; Punwani et al., 
2010; Punwani and Kieber, 2010). Type-B ARRs are transcription factors activated by 
phosphorylation (Mason et al., 2005). Type-A ARRs lack a DNA-binding domain, are cytokinin-
inducible, and negatively regulate cytokinin signaling (To et al., 2004; To et al., 2007).  
The cytokinin AHK receptors are encoded by AHK2, AHK3, and AHK4/CRE1 in 
Arabidopsis. Multiple mutant lines with various loss-of-function T-DNA insertion alleles of each 
gene have been identified. The most severely affected triple mutant line, ahk2-7 ahk3-3 cre1-12, 
harbors null alleles for ahk2 and ahk4, but still contains residual full-length wild-type transcript 
for AHK3 (Cheng et al., 2013). We sought to identify a CRISPR-induced null allele of ahk3 in an 
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ahk2 ahk4 background by introducing a frameshift mutation in AHK3. This would reveal the 
effect of complete disruption of the AHK cytokinin receptors in Arabidopsis.  
The indCAPS tool was tested by designing primers for a CRISPR mutagenesis 
experiment targeting the AHK3 gene (Fig 4.3). A CRISPR/Cas9 target was designed to target the 
first exon of AHK3 using the CRISPR-Plant resource (Xie et al., 2014). The target site chosen is 
before the Cyclases/Histidine kinases Associated Sensory Extracellular (CHASE) domain, the 
cytokinin binding domain of the AHKs. The AHK3 targeting plasmid, pCH59, was stably 
transformed into an ahk2-7 cre1-12 mutant line (Inoue et al., 2001; Yamada et al., 2001; Cheng 
and Kieber, 2013), referred to as ahk2,4 hereafter. The pCH59 vector was constructed by cloning 
a commercially synthesized gRNA fragment into a pCUT binary vector system expressing plant 
codon optimized Cas9 (Peterson et al., 2016). T1 transformed seedlings were identified by 
hygromycin selection and grown to maturity. The T2 progeny were screened for AHK3 editing 
events using primers generated by indCAPS. Viable seedlings with homozygous, single base pair 
insertions causing frameshift mutations disrupting the AHK3 coding region were identified. 
These alleles, denoted ahk3-9 and ahk3-10, are single base pair insertions of A and C, 
respectively. The frameshift produces an early stop codon 25 residues after the edit location. The 
resulting predicted protein retains two transmembrane domains, but no functional CHASE 
domain or cytosolic histidine kinase or receiver domains. These triple cre1-12 ahk2-7 ahk3 
mutants were viable and resembled the cre1-12 ahk2-7 ahk3-3 (Argyros et al., 2008). These 
results demonstrate that the complete disruption of all three AHK cytokinin receptors does not 
result in embryo lethality. As these are the only CHASE-domain containing proteins in 
Arabidopsis, this suggests that either cytokinin is not essential for early development, or that 
there are other as yet unidentified cytokinin receptors.  
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In addition to analysis of CRISPR-induced ahk4 alleles, indCAPS tool has been 
successfully use by multiple other members of the authors’ research groups to successfully target 
at least five additional genes. 
 
Figure 4.3. Homozygous editing events in AHK3were identified. (A) The indCAPS package was used to generate a primer 
recognizing a Bsa BI site spanning the CRISPR cut site (between the green bases). A single mismatch was required in the primer 
(indicated in red). The genomic locus for AHK3 is shown. Boxes indicate exons, red bars—transmembrane domains, black 
region—CHASE domain, grey region—histidine kinase domain, yellow region—receiver domain, blue region– 3’ UTR. 
Locations of T-DNA insertion sites (ahk3-1, ahk3-3, and ahk3-7) and targeted editing site are indicated. (B,C) The assay was 
used to screen A. thaliana plants stably transformed with a pCUT binary vector system (Peterson et al., 2016) and sgRNA 
constructs targeting AHK3. (B) Wild-type controls at edit location. (C) T2 plants from two representative independent 
transformation events are shown. The uncut amplicon is 90 bp and the wild-type allele is cleaved to produce 36 bp and 54 bp 
fragments. (D) Progeny from two T2 plants heterozygous for editing events were selected and analyzed for editing. (E) A. 
thaliana seedlings imaged at 2.5 weeks of growth. Shown are Col-0; ahk3-3; ahk2,4; ahk2-5 ahk3-7 cre1-12; ahk2-1/+ ahk3-1 






The indCAPS package provides a useful tool for researchers using CRISPR-mediated 
mutagenesis as it facilitates the screening of individuals in which editing of the target has 
occurred. It also provides replacement for existing tools for the design of primers for dCAPS 
analysis capable of distinguishing known indel alleles. We employed this tool to successfully 
design diagnostic primers to identify CRISPR-induced ahk3 null alleles, the subsequent analysis 
of which showed that the cytokinin AHK receptors are not essential for embryo development. 
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CHAPTER 5: CONCLUSION 
The scientist as a craftsman 
If you are reading this work and made it to this conclusion, you are almost certainly a 
scientist. And if you are reading a biologist’s dissertation, you are likely yourself a biologist, or 
may know a few. For a moment, please pretend you are not. Imagine that you are a child, or an 
adult in nearly any other profession, and you are on a tour of a laboratory. Your guide walks you 
past some desks, some computers, some objects that your guide calls microscopes but that look 
nothing like the tools you used in your science classes, and into an open area full of counters. 
The counters are covered with the worst mess you have seen in your life, and you feel sorry for 
anyone who must use them. Your guide refers to these counters as “benches.” This name strikes 
you as odd. These are waist-high counters with shelves and drawers, not a chair you might find 
at a park or bus stop. And after a moment, the epiphany: your guide means a workbench, not a 
sitting bench. 
I bring this to your attention, reader, because I believe that the workbench is a perfect 
simile for the contents of this dissertation (also because it’s a moment of confusion even I have 
from time to time, and I believe the occasional brain fart is part of what makes us human). Some 
time ago, I came across the Youtube channel of a woodworker named Rex Krueger. One of the 
first videos I watched dealt with his fascination with English joiners’ benches. Those joiners’ 
benches were sturdy, purpose-built tools crafted in every detail to aid the work of the joiner. He 
proceeded to build one himself, describing his thought process at each step and how he used the 
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scrap wood from the project to further enhance the bench. He had a goal. He attempted to reach 
it. He ran into problems, looked at his available resources, thought carefully, and addressed the 
problems. His bench was a scientific bench, even though it was made of 2x8 lumber. 
Similarly, this dissertation is a bench. I did not begin my graduate career with the 
intention of developing tools for other scientists. My goal was to discover new facts about 
hormone signaling in plants. In the pursuit of that goal, I discovered problems – problems of 
time, of complexity, and of absent tools. Giving up was not an option, so I looked at my 
available resources and found a way forward. I solved my problems and incorporated the 
solutions into my work. After many years, what I am left with is a joiner’s bench built of words 
rather than wood. 
I discovered new facts about cytokinin signaling, and in that, I accomplished my original 
goal. In addition, I made improvements to my own toolset that I hope will be useful to many 
other researchers around the world. In the modern era, CRISPR/Cas9-derived mutant alleles are 
common, but there were problems with the screening tools that I and other plant molecular 
biologists used. PCR-based restriction digest genotyping is a quick and easy technique that 
should be part of every molecular biologist’s basic tool kit, but the existing tools were not 
compatible with insert/deletion alleles without difficult workarounds or manual primer creation.  
A member of my committee, Zack Nimchuk, was aware that I possessed experience in 
programming and suggested that I update the tools. After a lot of trial and error, I developed an 
algorithm that would work and implemented both the code and web portal to make a tool that 
any scientist could use. There are many ways to genotype an organism or screen for new 
mutations, but the ease with which PCR can be parallelized makes it an attractive method. I hope 
that future scientists will find that the indCAPS tool makes their lives easier. 
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Similarly, mutant screens are nothing new. Screens are a foundational tool for a 
geneticist, but it can take tremendous time and effort to characterize a mutant obtained from a 
screen. I performed the eah screen in order to identify genes with an unknown role in cytokinin 
signaling. I came out with one gene with a little recognized role in cytokinin signaling (HY5) and 
several excellent candidates for further study that I hope will yield fertile ground for future 
scientists. In the process, I used high throughput sequencing and my knowledge of 
bioinformatics to develop strategies to identify the low-hanging fruit in the experiment and 
accelerate the pace of discovery of novel mutations, and I implemented those strategies in a set 
of scripts and pipelines that any end-user should be able to use to gain new insights about their 
screen. 
In fact, mutagenomics has already yielded results for other scientists. The acre screen, 
performed within our own research group, had an lht1 mutation confidently implicated as 
causative for several of the mutant lines in the experiment. The gob screen does not yet have 
final confirmed causative mutations, but the sheer number of sibling groups in the gob 
experiment should keep researchers busy for years to come and hopefully will provide many new 
avenues of research to the Nimchuk group. 
Additional avenues of research for the work described in this thesis remain. For example, 
we have shown that HY5 is involved in cytokinin signaling through genetic means, but the 
mechanism of interaction is unknown. HY5 proteins have binding sites near many of the same 
genes as type-B ARRs, but whether this is the result of HY5 and ARRs sharing a common set of 
target genes for regulation or whether this represents interaction as a dimer or members of a large 
protein complex is unknown. Additional experiments are required to explore further whether 
HY5 and any of the ARRs interact. Some negative data has been collected regarding ARR and 
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HY5 interaction via a bimolecular fluoresence complementation assay, but other experiments 
such as a co-immunoprecipitation or a fluorescence resonance energy transfer assay could be 
attempted. Complementation tests have only been performed for five of the lines observed to 
have ahk4 mutations; the other putative ahk4 lines should be crossed to an ahk4 T-DNA to 
confirm the causative nature of the ahk4 mutations. 
There are also wholly uncharacterized lines. At least one sibling set and several 
promising independent lines have SNP densities low enough they can be manually screened for 
plausible candidate mutations, but several other lines remain uncharacterized and have high SNP 
densities. These lines should be pursued with both mutagenomic and traditional mapping 
approaches. If additional siblings for these lines can be identified, then they should be 
sequenced, and in the meantime while the search for siblings is underway, they should be back-
crossed to ahp2,3 plants for a mapping experiment. 
Uncharacterized mutants in the acre and gob screens remain as well. The acre screen is 
likely to require traditional mapping-by-sequencing efforts, but if siblings can be identified for 
any of the acre lines, mutagenomics may be helpful. Also, many of the gob sibling sets and 
independent lines are amenable to manual screening for candidate mutations. It is my hope that 
the lines identified by mutagenomics in the gob screen are fruitful areas of research for future 
scientists. 
Finally, the current software pipeline for mutagenomics is implemented as a set of scripts 
and programs the end user must download to their computer and run from the command line. I 
have provided written instructions, but it would be useful in the future to create a website where 
users could upload their files of mutant SNPs and receive network files automatically. This is 
likely to require funding source for a website to host it. While the computational work in the 
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mutagenomics pipeline is light enough that a laptop can perform it it is not an immediate or 
computationally cheap process and free hosting services may not be sufficient to run the 
pipeline.  
What I am left after many years is a combination of new knowledge and new techniques. 
It may not be the prettiest collection of ideas, but it fits together snugly. The new facts are 
inextricably intertwined with the new methods, and to discuss one without the other would be to 
tell an incomplete story. My hope is that this work will continue to support the work of other 


























Figure A1.1. Full network diagram of PA-SNPs. Yellow boxes represent individual mutant lines. Blue circles represent genes. 
Gene objects are scaled proportionally to the number of mutations observed in each gene. Lines are drawn from boxes to circles 






Figure A1.2. Comparison of differentially expressed genes between BA and control-treated wild type plants (green) and hy5 
control plants and wild type control plants (red). Differentially expressed genes are at least 0.5-fold different (on a log2 scale) 
with BH-adjusted p-value < 0.02. All overlaps are significant by a hypergeometric test. P-values are 8.1e-40 for the BA-up vs 




Figure A1.3. Exact shared SNPs between eah14-1 and eah14-2. Although these siblings (yellow circles) share only one 
homozygous PA-SNP, examination of the shared EMS-derived SNPs (blue circles) confirms that they are sibling lines. Each 
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